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The placenta is a transient but vital organ mediating a myriad of interactions 
between maternal and embryonic tissues. The cells in the trophectoderm (TE) lineage are 
responsible for proper implantation, placentation, and immunological functions of the 
placenta. However, our understanding of molecular mechanisms underlying placentation 
and TE development is still rudimentary. Deciphering the mechanisms by which key TE-
specific transcription factors (TFs) control the first cell fate decision, as well as the 
maintenance and differentiation of TE, is a prerequisite for understanding early 
embryonic development and ultimately improving healthy pregnancy. 
First, using a combination of functional genomics, bioinformatics, and mouse 
genetics, I revealed that Arid3a is a critical regulator for controlling the first cell fate 
decision and placental development. Ectopically expressed Arid3a induces TE-like gene 
expression programs in embryonic stem (ES) cells. Moreover, Arid3a is not only 
essential for maintaining self-renewing TS cells, but also for promoting further 
differentiation of trophoblastic lineages. Consistently, Arid3a-/- mice suffer from 
severely impaired post-implantation development, resulting in early embryonic lethality. 
I further showed that Arid3a directly activates TE-specific genes while repressing 
 viii 
pluripotency genes by recruiting HDAC1. Second, I studied the mechanisms underlying 
TF-mediated conversion of ES to trophoblast stem (TS)-like cells. Upon overexpression 
of TS cell-specific TFs, Cdx2, Arid3a, and Gata3 (CAG factors) in ES cells, I performed 
time–course profiling of chromatin accessibility, transcriptomes, and occupancy of these 
reprogramming factors during reprogramming. Using an integrative analysis, I 
discovered that CAG factors orchestrate the conversion via a sequential two-step 
regulation in a timely, ordered manner, with repression of pluripotency genes by 
decommissioning active enhancers, followed by activation of TS cell-specific genes as 
pioneer factors that can access closed chromatin. 
Taken together, my studies unveiled that Arid3a functions as a pivotal regulator 
of TE and placental development by regulating the commitment to the first cell fate, as 
well as by executing TE lineage differentiation. I advanced our understanding of the 
mechanisms underlying TF-mediated reprogramming of ES to TS-like cells, in particular 
Arid3a-mediated transcriptional and epigenetic regulation. Thus, my studies will be 
beneficial for enhancing clinical applications such as disease modeling, drug screening, 
and regenerative therapies. 
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CHAPTER 1: GENERAL INTRODUCTION 
1.1 EARLY MAMMALIAN EMBRYOGENESIS 
During early embryogenesis, the totipotent single cell zygote undergoes a sequence of 
cell divisions accompanied by distinct cellular, molecular, and epigenetic changes, 
ultimately leading to the partitioning of cells in the developing blastocysts according to 
their cell fates (Hemberger et al., 2009; Tarkowski, 1959; Zernicka-Goetz et al., 2009). 
These cells develop into three morphologically distinct lineages by the late blastocyst 
stage of preimplantation (Kelly, 1977; Ralston and Rossant, 2005). The outer layer of the 
late blastocyst, or trophectoderm (TE), will develop into the placenta and invade the 
maternal endometrium to form the intervillous space, which links the growing fetus to the 
mother(Arnold and Robertson, 2009). The inner layer of the blastocyst is the inner cell 
mass (ICM), which later differentiates into two distinct tissues: the inner epiblast (EPI) 
cells and an outer layer of primitive endodermal (PE) cells facing the blastocoel (Dyce et 
al., 1987; Grabarek et al., 2012). While the PE cells are restricted to the yolk sac, EPI 
cells can give rise to all adult tissues (Arnold and Robertson, 2009). From the 
aforementioned cell lineages, three types of stem cell models have been established: (1) 
trophoblast stem (TS) cells from the TE, (2) extraembryonic endoderm stem (XEN) cells 
from the PE, and (3) embryonic stem (ES) cells from the EPI or earlier stages of the ICM 
(Cahan and Daley, 2013; Rossant, 2008). These stem cells serve as invaluable in vitro 
model systems that help illuminate the mechanisms underlying early embryogenesis, as 
well as lineage specifications, and enable stem cell therapies, which may be used to treat 
numerous disorders and injuries in the future. 
OVERVIEW OF PREIMPLANTATION DEVELOPMENT 
During the initial rounds of zygotic cleavage, the cells are morphologically identical 
and are distributed symmetrically within the embryo until compaction at the eight-cell 
(morula) stage, which is when these cells become adhesive and polarized (Johnson, 2009; 
Rossant, 2004). Junctional complexes are gradually formed at apicolateral and lateral 
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sites, followed by polarization of outer cells (Bischoff et al., 2008). Compaction and 
polarization during the morula stage generate cellular asymmetry, leading to regression of 
totipotency and formation of the polarized outer and apolar inner compartments—the TE 
and the ICM, respectively (Dietrich and Hiiragi, 2007). This segregation process is 
termed the first cell fate decision, after which these two groups of cells diverge sharply in 
terms of transcriptional and epigenetic regulation during development (Johnson and 
Ziomek, 1981; Rossant and Tam, 2009; Zernicka-Goetz et al., 2009). Mouse and human 
embryos undergo similar embryonic developmental processes, although the timeline to 
reach the blastocyst is delayed in humans compared to mouse embryos (Niakan et al., 
2012). 
Despite intensive studies that have advanced our understanding of embryogenesis 
over recent years, it is still not well-understood how the first cell fate decision and lineage 
specification are controlled by signaling pathways, as well as global transcriptional and 
epigenetic regulatory mechanisms. 
THE FIRST CELL FATE DECISION: INNER CELL MASS (ICM) AND TROPHECTODERM (TE) 
Both cell polarity and position in the embryo influence the first cell fate decision. 
Upon blastocyst formation, the cleavage plane and polarization axis are perpendicular, 
resulting in the formation of inner apolar and outer polar cells (Jedrusik et al., 2008; 
Suwinska et al., 2008). Inner apolar cells are progenitors of the pluripotent ICM, which 
can engender all three germ layers, including the mesoderm, endoderm, and ectoderm, 
whereas the outer polar cells are antecedents of the multipotent TE that can be 
differentiated into all the cells of the placenta (Takaoka and Hamada, 2012). In addition, 
cell polarity and cell position cross-regulate one another, as transplantation of inner cells 
to an outside position results in polarization and adaption to the TE fate. On the other 
hand, downregulation of key polarity molecules such as aPKC (atypical protein kinase C) 
and PARD3 (par-3 family cell polarity regulator) promotes allocation of the cells to 
inside positions (Pauken and Capco, 1999; Plusa et al., 2005). Although segregation of 
the ICM and the TE becomes apparent as polarization of blastomeres occurs, cells are not 
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yet fully committed toward ICM or TE lineages at the 16-cell stage (Dietrich and Hiiragi, 
2007). Manipulation of the cells at this stage can alter their cell fate; thus, they are still 
plastic and totipotent. Cell fate is further determined by signaling cascades of 
environmental cues, followed by changes in transcriptional activities coupled with 
selective epigenetic marks. 
The mechanisms underlying the first cell fate decision are remarkably complex and 
remain poorly understood. Recent studies identified substantial changes in the 
transcriptome during the first cell fate decision, suggesting important roles for 
transcription factor (TF) activities (Moignard and Gottgens, 2014). In addition, 
microRNAs (miRNAs) and epigenetic regulations also direct lineage specification 
(Kloosterman and Plasterk, 2006; Yang et al., 2008).  
Transcriptional regulation 
TFs play crucial roles during the development of the blastocyst. Importantly, some 
TFs show restricted expression patterns associated with the segregation of the ICM and 
the TE. For example, Nanog and Oct4 (Pou5f1) are expressed in ICM cells, but not in TE 
cells, while Cdx2 is exclusively expressed in the TE (Nichols et al., 1998; Strumpf et al., 
2005). These mutually exclusively expressed TFs not only serve as markers to distinguish 
between the ICM and the TE, but also play crucial roles in first cell fate determination. 
Oct4 and Cdx2 currently are considered to be the master regulators of the first fate 
decision based on their respective mutant phenotypes, distinctive gene expression 
patterns, and differential functions at the molecular level (Niwa et al., 2005). Initially, 
Oct4 and Nanog were identified as critical factors required for forming and maintaining 
the ICM because they become restricted to the ICM cells of the blastocyst (Mitsui et al., 
2003; Palmieri et al., 1994). However, subsequent genetic studies in mice revealed that 
both Oct4 and Nanog knockout (KO) embryos form blastocysts without obvious 
developmental defects (Mitsui et al., 2003; Nichols et al., 1998). Yet, ES cells, the in 
vitro counterpart of the ICM, cannot be easily derived from the ICM of these mutant 
embryos, nor do they behave as typical ES cells. For example, ES cells from Oct4-KO 
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embryos tend to differentiate into the extraembryonic trophoblast lineages, whereas ES 
cells from Nanog-KO embryos are prone to die via apoptosis (Mitsui et al., 2003; Niwa et 
al., 2000). These results suggested that Oct4 and Nanog are, instead, key regulators of 
pluripotency and self-renewal (Boyer et al., 2005). Consistent with these observations, 
recent genome-wide mapping of pluripotency factors, including Oct4, Sox2, and Nanog 
in ES cells, revealed that these pluripotency ICM factors tightly maintain their expression 
levels in the interwoven transcriptional gene regulatory network to auto-regulate and 
control one other through a feed-forward regulatory loop, and that this pluripotency 
network involves many additional TFs, epigenetic regulators, and miRNAs (Avilion et 
al., 2003; Boyer et al., 2005). 
On the other hand, Cdx2, a key TF in the generation of the TE, was first detected at 
the eight-cell stage of the embryo (Beck et al., 1995). Cdx2 is exclusively expressed 
within cells of the outer embryonic segment, while its expression is depleted in the ICM. 
Cdx2-KO embryos can initiate lineage commitment, but cannot maintain a blastocyst due 
to a lack of epithelial integrity in their outside cells (Strumpf et al., 2005). This indicates 
that Cdx2 is crucial for both epithelial identity and trophoblast multipotency. In addition 
to Cdx2, other TE-specific TFs, including Eomes, Gata3, and Tfap2c, are also solely 
expressed in the TE (Home et al., 2009; Russ et al., 2000; Weber et al., 2010). Unlike 
Cdx2, embryos deficient in any of these factors are able to form a blastocyst, but fail after 
implantation due to defects in more differentiated placental tissues. These results indicate 
that these factors are required later during TE development. Deletion of another TE-
specific gene, Tead4, results in preimplantation lethality, suggesting that its function is 
upstream of Cdx2 (Nishioka et al., 2008). Tead4-KO embryos fail to activate TE-specific 
genes, including Cdx2, without an alteration of ICM-specific gene expression, such as 
Oct4 and Nanog, throughout all blastocysts (Nishioka et al., 2008; Yagi et al., 2007). 
Thus, Tead4 is crucially required for TE, rather than ICM, development (Nishioka et al., 
2008). During the process of TE specification, Tead4 cooperates with its co-activator, 
Yap1, to activate TE-specific genes (Nishioka et al., 2009). Likewise, Gata3 participates 
in TE development downstream of Tead4 but in parallel to Cdx2 (Home et al., 2009; 
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Ralston et al., 2010). In addition to TFs, Fgf signaling, which is mediated by Ras/Erk 
signaling, is essential for trophoblast expansion and the sequential induction of TE-
specific TFs (Maekawa et al., 2005; Yamauchi et al., 1994). 
While ICM-specific TFs positively regulate one another, and the same is observed for 
TE-specific TFs, ICM-specific TFs tend to antagonize TE-specific TFs and vice-versa, 
which is fundamental to the decision of ICM vs. TE cell fate. For instance, Oct4, Nanog, 
and Cdx2 directly repress each other to determine whether cells develop into ICM or TE 
lineages (Strumpf et al., 2005; Zernicka-Goetz et al., 2009). Although our knowledge of 
the mechanisms underlying ICM and TE segregation has considerably expanded, many 
questions remain unanswered. For example, how do the key TFs interact with epigenetic 
regulators, such as histone-modifying enzymes and/or chromatin remodelers, to activate 
or suppress gene expression? Which additional TFs are essential for blastocyst 
development, and what are the critical downstream targets of these TFs? How are these 
factors themselves regulated within the pluripotency or TE-specific network? Answers to 
these central questions will elucidate the fundamental mechanisms underlying 
pluripotency of the ICM and multipotency of the TE lineages, as well as advance stem 
cell-based future cell therapies. My thesis project has focused on tackling several of these 
fundamental questions. 
Epigenetic regulation 
From zygote to blastocyst formation, the epigenome, including DNA methylation and 
histone modifications, changes dramatically, and these changes influence developmental 
potential (Morgan et al., 2005; Rougier et al., 1998). Asymmetric epigenetic marks are 
tightly associated with segregation between the ICM and TE (Reik et al., 2003). 
Recently, DNA methylation and histone modifications have been shown to be 
indispensable for growth and differentiation of the extraembryonic lineages, suggesting 
that such modifications, are essential for proper embryonic development (Santos and 
Dean, 2004; Zheng et al., 2016). In particular, histone methylation signatures such as 
H3K4me3 and H3K27me3, are enriched at the promoters of ICM-specific genes 
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exclusively expressed in ICM- and TE-specific genes that are highly expressed in TE. 
(Li, 2002) Distribution of H3K27me3 and H3K9me3 in ICM and TE are correlated with 
lineage specification to embryonic vs. extraembryonic tissues (Rugg-Gunn et al., 2010). 
For example, a histone methyltransferase enzyme, ESET, maintains pluripotency of the 
ICM through catalyzing a repressive H3K9me3 mark at the promoter of Cdx2 (Carlson et 
al., 1992; Yeap et al., 2009; Yuan et al., 2009). In contrast, in the TE lineage, 
methyltransferase Suv39h mediates H3K9me3 at regulatory regions of ICM-specific 
genes (Alder et al., 2010; Rugg-Gunn et al., 2010). Each of these histone modifications 
cooperates with developmental-specific TFs to mediate spatial and temporal expression 
of lineage-specific genes. 
Signaling pathways 
The Hippo signaling pathway regulates cell fate during embryonic development in 
position-, cell-polarity-, and density-dependent manners (Harvey and Hariharan, 2012). 
After the 16-cell stage, Tead4, a downstream effector of the Hippo signaling, is active in 
outer polar cells to promote TE development (Nishioka et al., 2008). In contrast, cell–cell 
interactions in the inner apolar cells activate the Hippo pathway, which sequesters Yap1 
in the cytoplasm, prevents co-activation with Tead4, and promotes the ICM fate. 
Although Hippo signaling is spatially regulated at the 16-cell stage, segregation of ICM 
and TE fate is not clearly patterned until the 32-cell stage. This may be due to another 
signaling pathway, the Notch pathway, which activates TE-specific genes. A key 
component of the Notch signaling, RBPJ (also known as CBF1), has stochastic activation 
up to the morula stage and gradually becomes restricted to the outer cells around the 32-
cell stage (Cormier et al., 2004). Thus, the Notch and Hippo pathways cooperate to 
establish segregation of the ICM and TE, which is clearly observed after the 32-cell stage 
(Rayon et al., 2014). 
Ultimately, crosstalk between multiple signaling pathways – Hippo, Notch, as well as 
the MAPK pathway – helps regulate cell fate determination in preimplantation embryos. 
However, further studies are needed to determine other regulatory inputs to lineage 
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specification at this critical developmental time point to fully understand the mechanisms 
underlying the first cell fate decision. 
SECOND LINEAGE SPECIFICATION IN PREIMPLANTATION 
Shortly after the first cell fate decision, ICM cells differentiate into EPI and PE lineages, 
which is known as the second lineage specification, and this is mediated through 
FGF/MAPK signaling and differential expression of key TFs, such as Nanog and Gata6 
(Baussano et al., 2006; Koutsourakis et al., 1999; Morrisey et al., 1998). FGF signaling 
orchestrates reciprocal repression between TFs specific for the EPI and PE lineages 
(Frum and Ralston, 2015). Specifically, Nanog and Gata6, present in all ICM cells until 
the 32-cell stage, become restricted to either the EPI or PE, respectively. Other TFs, 
including Gata4 and Sox17, also contribute to the specification of EPI vs. PE lineage 
within the mouse ICM (Chazaud et al., 2006; Niakan et al., 2010). The expression 
profiles of these TFs are conserved between human and mouse (Artus and Chazaud, 
2014). However, unlike PE formation in the mouse, human embryos are not dependent 
upon FGF signaling, implying alternative undiscovered signaling pathways might be 
likely critical for second fate specification in human embryos.  
IMPORTANCE OF PLACENTAS 
The TE ultimately differentiates into all the specialized cells of the placenta, which 
nourishes and safeguards the fetus during pregnancy by mediating exchange of nutrients, 
gases, and waste between mother and fetus, immune protection of the fetus, and secretion 
of growth factors and pregnancy-related hormones (Cross et al., 1994; Rossant and Cross, 
2001). Placental health is essential for a successful pregnancy. In mice, placental tissues 
are composed of multiple specialized cell types, including trophoblast giant cells, 
spongiotrophoblasts, and syncytial trophoblasts (Cross, 2005; Rossant and Cross, 2001). 
The failure of normal TE development can cause mortality and developmental defects not 
only during pregnancy, but also after birth (Farquharson et al., 2005). The molecular 
basis of preimplantation is poorly understood despite its crucial importance in pregnancy 
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health. Thus, the discovery of biomarkers of early placental development will not only 
serve as diagnostic markers in gynecology, but also will catalyze the development of 
treatments to save lives of mothers and their fetuses from pregnancy-related disorders. 
1.2 IN VITRO MODEL SYSTEMS OF EARLY EMBRYOGENESIS 
Stem cells are self-renewing (meaning they can renew themselves indefinitely) and either 
multipotent or pluripotent (meaning they can differentiate into other, more specialized 
cell types). All blastocyst lineages discussed earlier can be used to derive stem cells for 
tissue culture; these cells can indefinitely self-renew under appropriate culture conditions 
and be induced to differentiate in vitro or incorporate into the developing embryos ex 
vivo.  
EMBRYONIC STEM (ES) CELLS 
Embryonic stem (ES) cells were first derived from the ICM of mouse blastocysts (Evans 
and Kaufman, 1981; Thomson et al., 1998). To maintain their self-renewal and 
pluripotency, they are cultured either on feeder layers of mouse embryonic fibroblasts 
(MEFs) or without feeders in the presence of leukemia inhibitory factor (LIF) or under 
serum-free conditions supplemented with Mek and GSK3 kinase inhibitors (this latter 
condition is termed “2i”) (Evans and Kaufman, 1981; Silva et al., 2008). The 
combination of 2i and LIF sustains the self-renewing “ground state”; ie, a basal 
proliferative state that is free of epigenetic restriction and has minimal requirements for 
extrinsic stimuli. Recent intensive studies have revealed that mouse ES cells express 
many critical factors including stage-specific embryonic antigens (SSEA-1 and SSEA-3) 
and TFs that are required for early ICM development such as Oct4, Sox2, and Nanog 
(Chambers et al., 2003; Loh et al., 2006). ES cells are karyotypically stable, capable of 
generating chimeras and transgenic mice, and able to form the ectoderm, endoderm, and 
mesoderm in culture, but they cannot contribute to the TE lineages of the placenta (Yu 
and Thomson, 2008). 
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Several years after mouse ES cells were established, human ES cell lines have also 
been derived, which share some conserved features (Thomson et al., 1998). Similar to 
mouse ES cells, human ES cells require an OCT4/SOX2/NANOG regulatory module 
(Boyer et al., 2005). They also express surface markers such as SSEA-3, SSEA-4, and 
TRA-1, and other factors including epigenetic regulators, miRNAs, and signaling 
molecules that played important roles in mouse ES cells. However, key differences exist. 
For example, human ES cells do not require the LIF growth factor for self-renewal (Hirai 
et al., 2011; Niwa et al., 1998). More importantly, human ES cells possessed 
transcriptional and epigenetic profiles more similar to those of mouse epiblast stem cells 
(EpiSC, derived from epiblast of inner cell mass) compared to mouse ES cells (Hanna et 
al., 2010). Interestingly, some studies, although controversial, suggested that human ES 
cells are able to differentiate into TE/TS-like cells under appropriate culture conditions 
(Bernardo et al., 2011; Li et al., 2013; Xu et al., 2002). Thus, further studies establishing 
interspecies differences are required and observations from mouse ES cells cannot be 
uniformly extrapolated to human ES cells. 
The pluripotency transcriptional network 
Genetic studies in combination with high-throughput knockdown (KD) screening 
revealed that many critical regulators (including sequence-specific TFs, chromatin 
modifying enzymes, chromatin remodelers, miRNAs, and non-coding RNAs) are 
indispensable for maintaining self-renewal and pluripotency (Ding et al., 2009; Zhang et 
al., 2006). Genome-wide target mapping of sequence-specific TFs has unveiled the core 
transcriptional network of pluripotency factors, composed of Oct4, Sox2, and Nanog, 
which are essential, as well as other TFs with partially redundant activities such as Klf4, 
Esrrb, and Tbx3 (Chen et al., 2008; Kim et al., 2008; Loh et al., 2006; Orkin et al., 2008).  
Oct4 is a key master regulator that sits atop of the hierarchy of the pluripotency 
regulatory network. Self-renewal and developmental potential of ES cells are both highly 
sensitive to either up- or down-regulation of Oct4 expression. For example, Oct4-High 
cells are more prone to differentiate into the primitive endoderm, whereas Oct4-Low cells 
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tend to differentiate into TE lineages (Niwa et al., 2000). Sox2 is a well-known 
interaction partner of Oct4, and alteration of Sox2 levels also disrupts the pluripotency of 
ES cells. For instance, both Oct4- and Sox2-KO ES cells cannot self-renew and tend to 
trans-differentiate/reprogram to TE lineages (Hay et al., 2004). In the pluripotency 
network, Oct4 and Sox2 positively regulate each other and co-occupy the vast majority of 
active enhancers of ES cell-specific genes to sustain the self-renewing status of ES cells. 
In addition to the activation of pluripotency genes, development-related genes must 
be suppressed to maintain self-renewal in ES cells. Some pluripotency factors may 
repress development-related genes by occupying regulatory regions. Importantly, 
multiple factors, including histone modifying enzymes and histone remodeling 
complexes such as Hdac1, Mta1, and Mbd3 (the NuRD complex) as well as the 
Polycomb complex (PRC1 and PRC2) and SWI/SNF complex (Brg1 and Baf155), are 
also implicated in developmental gene repression (Chen and Dent, 2014; Lessard and 
Crabtree, 2010). In particular, most developmental genes are marked by a bivalent 
histone signature consisting of both H3K4me3 and H3K27me3, which is considered to be 
the “poised status” for rapid activation upon differentiation (Bernstein et al., 2006). In 
summary, key ES cell-specific TFs orchestrate transcriptional gene activation and 
repression in conjunction with chromatin regulators within the pluripotency network to 
sustain self-renewal and pluripotency of ES cells. 
TROPHOBLAST STEM (TS) CELLS 
TS cells can be isolated from the polar TE of mouse embryos and maintained in a 
proliferative and undifferentiated state in vitro in the presence of Fgf4 (fibroblast growth 
factor 4) with its cofactor, heparin, and a feeder layer of MEFs (Tanaka et al., 1998). TS 
cells are self-renewing and multipotent. Upon withdrawal of Fgf4, the vast majority of 
cells become terminally differentiated into trophoblast giant cells, while a small portion 
of cells differentiate into other trophoblast lineages, including spongiotrophoblasts and 
labyrinthine cells. Following their injection into an early embryo, TS cells can participate 
in the development of chimeras in which they contribute exclusively to trophoblastic 
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components of the placenta and parietal yolk sac, in contrast to ES cells, whose 
contributions are restricted to the three germ layers (Tam and Rossant, 2003). 
Multiple TFs, serum factors, and signaling pathways, such as Ras/Mapk signaling, 
maintain the self-renewal and multipotency of TS cells by upregulating TS cell-specific 
TFs such as Eomes (which only requires one of the two signaling pathways) and Cdx2 
(which requires both) (Lu et al., 2008). In drastic contrast to the roles of ICM and ES 
cells, placental biology, including TE differentiation, is poorly understood despite the 
critical importance of trophoblast lineage development for successful mammalian 
reproduction. Therefore, it is vital to elucidate critical factors and mechanisms underlying 
TE differentiation and placental biology. Importantly, human TS cells are not yet 
available, mainly due to ethical issues, such as the necessity of destroying human 
embryos. 
Interestingly, spontaneous differentiation of human ES cells to the TE lineage, which 
is called trans-differentiation, can occur infrequently. The most common method to 
induce trans-differentiation is by BMP4 treatment of ES cells (Xu et al., 2002). BMP4 
down-regulates the expression of OCT4, SOX2, and NANOG in ES cells, thus promoting 
their conversion to TS-like cells through the induction of TS cell-specific TFs, including 
TEAD4 and GATA3. Despite dramatic changes in cell morphology and global gene 
expression that are similar to the human TE, these TS-like cells are mixed cultures that 
express TE and mesodermal and vascular endothelial cell markers, suggesting that BMP4 
treatment alone is insufficient to induce complete trans-differentiation toward TE lineage 
(Bernardo et al., 2011). Although as yet not fully successful, diverse attempts have been 
made to induce human TS-like cells from ES cells by inhibiting the Activin/Nodal 
pathway or by the addition of Fgf2 (Sarkar et al., 2015; Yu et al., 2011). This is 
unfortunate, as it is essential to develop a well-characterized model of human TS cell 
differentiation to understand early human placentation and inform therapeutic 
interventions for pathological pregnancies. 
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Core TS cell-specific transcription factors 
A group of key TS cell-specific TFs, including Tead4, Cdx2, Gata3, Eomes, Elf5, and 
Tfap2c, positively regulate one another to orchestrate TS cell-specific gene expression 
(Kuckenberg et al., 2010; Ralston et al., 2010). In contrast to ES cells, TS cells do not 
require the LIF-Stat3 signaling pathway; instead, they need Ras/Mapk and Nodal 
signaling to maintain self-renewal (Roberts and Fisher, 2011). Notably, depletion of any 
one of a subset of TFs (e.g., Tead4, Gata3, Elf5, Tfap2c, and Ets2) leads to lethality of 
the mouse embryo due to defects in proper TE differentiation (Auman et al., 2002; 
Donnison et al., 2005; Home et al., 2009; Nishioka et al., 2008; Okada et al., 2007). This 
further suggests key roles for these TFs in placental biology. Ectopic expression of Gata3 
and Elf5 in TS cells abrogates self-renewal of TS cells, indicating that the precise levels 
of some of these TS cell-specific TFs are crucial for the balance between self-renewal 
and differentiation. 
Genetic studies in mice further revealed a hierarchical regulation among the TS cell-
specific TFs. Tead4, the most upstream factor, controls the levels of Cdx2, Eomes, and 
Elf5 (Latos et al., 2015; Niwa et al., 2005; Ralston et al., 2010). Functional and 
mechanistic studies of Cdx2 further disclosed that Cdx2 not only auto-regulates itself but 
also is controlled by multiple TS cell-specific TFs, such as Gata3. Unfortunately, only a 
few TS cell-specific regulators have been identified, exhaustive mapping of genome-wide 
DNA binding sites of TS cell-specific TFs has not been achieved, and epigenetic 
regulation of TE gene expression remains relatively uncharacterized. Many questions 
remain unanswered, including: How do these TS cell-specific TFs control self-renewal 
and modulate differentiation of TS cells toward more specialized placental cell types? 
How do they interact with their DNA targets, histone modifying enzymes, and 
remodelers? These central questions constitute a major challenge for future investigation. 
CROSS TALK BETWEEN PLURIPOTENCY AND EPIGENETIC FACTORS IN ES AND TS CELLS 
The balance of pluripotency TFs and epigenetic modifications is critical to maintain 
stemness in ES cells. The complexes of epigenetic regulators, such as Polycomb (Eed, 
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Ezh2, and Suz12) and MLL (Wdr5 and Ash2l), are positively regulated by 
Oct4/Sox2/Nanog (Ang et al., 2011; Chamberlain et al., 2008; Pasini et al., 2007). 
Interestingly, both the Polycomb and MLL complexes are required to keep lineage-
specific genes silenced. Genome-wide DNA methylation patterns mediated by Tet 
proteins and DNA methyltransferases (DNMTs) also maintain the ES cell identity 
(Cimmino et al., 2011). Thus, crosstalk between the core pluripotency factors and 
numerous epigenetic regulators is required for maintaining ES cell self-renewal, as well 
as for ensuring proper cell differentiation. 
Unlike ES cells, only a few histone modifications have been globally investigated in 
TS cells. Among those, the levels of H3K27me3 appear to be globally lower in TS cells 
than in ES cells (Chuong et al., 2013). This is probably linked to the low expression 
levels of Eed, a component of the Polycomb complex, responsible for H3K27me3 
signatures. In addition, ChIP-seq analyses have revealed that few genomic regions in TS 
cells that are enriched for H3K27me3 are only rarely localized near transcription start 
sites. Moreover, H3K27me3/H3K4me3 bivalent domains, which restrain the expression 
of developmental genes in ES cells, are rather rare in TS cells (Chuong et al., 2013). 
However, a more recent study showed the existence of bivalency in TS cells (Liu et al., 
2016). Thus, further investigation is needed to understand TS cell biology on an 
epigenetic level. 
EXTRAEMBRYONIC ENDODERM STEM (XEN) CELLS 
For many years, mouse ES and TS cells have been used as model systems for 
ICM/EPI or TE biology in order to study mechanisms underlying embryonic and 
placental development, respectively (Evans and Kaufman, 1981; Tanaka et al., 1998). 
Recently, XEN cells have been successfully derived from mouse blastocysts at E3.5 
(Niakan et al., 2013). As with other stem cells, they can propagate indefinitely in vitro, 
while maintaining their ability to contribute to extraembryonic endodermal lineages after 
injection into blastocysts ex vivo. Although Gata6 and Gata4 are known to be the key 
XEN-specific TFs, these TFs are not homogeneously expressed within populations of 
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XEN cells (Capo-Chichi et al., 2005; Fujikura et al., 2002). It still remains unclear 
whether this heterogeneity represents distinct XEN cell types. Notably, isolated XEN 
cells are emerging as a useful stem cell model to understand the convergence of their 
signaling and transcriptional control of cell fate specification and differentiation, and thus 
provide another layer of control in developmental biology. 
1.3 REPROGRAMMING 
Cellular reprogramming is the process that allows conversion of one specific cell type 
to another. Nuclear reprogramming, first established using frog embryos, ultimately 
enabled animal cloning using somatic cell nuclear transfer (Gurdon and Melton, 2008; 
Wilmut et al., 2002). This technique allows de-differentiation of terminally differentiated 
cells into a stem-like state, refuting the principle of irreversible cellular differentiation. 
Though powerful, nuclear reprogramming has extremely low efficiency (Blelloch et al., 
2006). On the other hand, direct reprogramming of one cell type by delivery of critical 
molecules, such as TFs, miRNAs, and chemicals, into target cell types can cause 
dramatic changes in morphology, global gene expression, and epigenetic marks (Hanna et 
al., 2008; Wapinski et al., 2013). This technique is more efficient than nuclear 
reprogramming, though its mechanisms remain incompletely characterized. 
TRANSCRIPTION (TF)-MEDIATED DIRECT REPROGRAMMING 
The first instance of successful direct reprogramming was the conversion of 
fibroblasts into muscle cells by ectopically expressing the MyoD TF (Davis et al., 1987). 
More recently, Yamanaka’s group in Japan established a protocol for the generation of 
“induced” pluripotent stem (iPS) cells by the overexpression of a handful of TFs (Oct4, 
Sox2, Klf4, and Myc) in fibroblasts (Takahashi and Yamanaka, 2006). Like ICM-derived 
ES cells, iPS cells are self-renewing and pluripotent. Their success overcomes ethical 
issues in deriving ES cells from developing human embryos, thereby paving the way to 
develop future patient-specific stem cell therapy. For instance, patient-specific iPS cells 
may be generated from fibroblasts of a patient donor (e.g., a sufferer of Alzheimer’s 
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disease) followed by the correction of genomic mutations by genome editing approaches. 
These genome-edited cells can be re-introduced to patients for patient-specific stem cell 
therapy. In addition to iPS cells, numerous studies have recently reported defined TF-
mediated cell type conversions in a broad range of cell types, including fully functional 
induced neural (iN) cells and induced cardiomyocytes (iCMs) (Ieda et al., 2010; 
Wapinski et al., 2013). 
Mouse ES cells can be directly reprogrammed into extraembryonic lineages by the 
overexpression of single TFs, such as Cdx2 or Gata6, to derive TS- and XEN-like cells, 
respectively (Niwa et al., 2005; Shimosato et al., 2007). The morphology and global gene 
expression patterns of TS- and XEN-like cells are highly similar to their counterpart 
genuine cells, suggesting that TF-mediated reprogrammed cells may acquire proper 
characteristics in vitro. Although TF-mediated reprogramming from numerous cell types 
is possible, substantial obstacles remain, such as the inconsistencies in differentiation 
potential. This may suggest that there are still undiscovered TFs and/or epigenetic 
regulators necessary to augment the efficiency and speed of reprogramming. In addition, 
many protocols available now have been developed from the mouse model, and it is 
essential that they be translated to the human system. Notably, it has become possible to 
reprogram mouse fibroblasts into induced trophoblast stem (iTS) cells by introducing a 
handful of TFs, including Eomes, Gata3, Tfap2c, and Ets2 or Myc (Benchetrit et al., 
2015; Kubaczka et al., 2015). This new methodology will allow us to generate human 
iTS cells in the near future. 
MECHANISMS OF DIRECT REPROGRAMMING 
Reprogramming requires that cell-type specific genes of the original cell type must be 
repressed, while those of the target cell type must be activated. The mechanism of how 
this occurs is poorly characterized, particularly the repression aspect. Reprogramming to 
iPS cells can be broadly divided into two gene activation phases: a long stochastic phase 
followed by a shorter deterministic phase (Stadtfeld et al., 2008). At first, cells undergo 
increased proliferation and alteration in histone modification to initiate mesenchymal-to-
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epithelial transition. Later, cells enter an intermediate phase followed by long latency of 
the process. In this late phase, cells stochastically undergo an epigenetic reset, as well as 
activation of their target-specific transcriptional network, which stabilizes the 
reprogrammed cells. Another well-established gene activation mechanism during 
reprogramming is the ability by which ectopically expressed TFs act as “pioneer” factors 
(Zaret and Carroll, 2011). Pioneer factors initially bind to closed chromatin of genes 
specific to the target cell type. Once bound, pioneer factors subsequently interact with 
chromatin modifying enzymes or remodeling complexes to convert closed into open 
chromatin, thus de-repressing target cell-specific genes. For example, early in 
reprogramming, Oct4, Sox2, and Klf4 function as pioneer factors by accessing closed 
chromatin of distal regulatory elements of pluripotency genes, such as Esrrb and Sall4 
(Soufi et al., 2015). Ascl1, a TF capable of converting fibroblasts to iN cells, also works 
as a pioneer factor, showing that this concept extends beyond the reprogramming of 
fibroblasts to iPS cells (Wapinski et al., 2013). 
Interesting insights have been gained into the process of reprogramming, including 
the findings that cells undergo defined sequential molecular events in an apparently 
stochastic manner, and that these events are influenced by the choice and number of TFs, 
as well as the starting cell type. However, many questions remain unanswered; in 
particular, how do ectopically expressed TFs mediate gene repression? This missing 
mechanism is part of what my research has focused on. 
ES TO TS-LIKE CELL FATE CONVERSION 
ES cells can be trans-differentiated (a process also known as reprogramming) to TS-
like cells that are highly similar to genuine multipotent TS cells with respect to 
morphology and global gene expression (Kuckenberg et al., 2011). This represents an 
informative in vitro model for the investigation of factors and the mechanisms underlying 
the first cell fate decision. Several methods promoting ES to TS-like cell conversion have 
been reported, including KD of Oct4 and induction of trophoblast-specific TFs in ES 
cells (Niwa et al., 2000). Finally, ectopic expression of components implicated in the 
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Ras/Erk signaling pathway also induces conversion of ES to TS-like cells (Lu et al., 
2008). However, the mechanisms by which ES cell-specific genes are repressed while TS 
cell-specific genes are activated by these diverse manipulations remain elusive. 
Unfortunately, TS-like cells obtained through KD of Oct4 or induction of TE-specific 
TFs in ES cells thus far do not possess all properties of genuine TS cells. However, these 
TS-like cells do experience upregulation of core TS cell-specific regulators, and they can 
to be incorporated into the TE of developing embryos, where they contribute to placental 
lineages ex vivo (Niwa et al., 2005; Rhee et al., 2014). Consistent with this, recent work 
performed by our own group has shown that the OE of a single factor, Arid3a, a novel 
player in trophoblast lineage development, causes trans-differentiation of ES cells to TS-
like cells, even under ES cell culture conditions (Rhee et al., 2014). Arid3a achieves this 
by suppressing ES cell core pluripotency factors and activating TS cell-specific genes. 
Arid3a OE cells also were successfully incorporated into the TE of developing embryos, 
indicating that they perform equivalently to bona fide TS cells at least in a mouse model 
system. Thus, ES to TS-like cell reprogramming can serve as a good model for 
uncovering mechanisms underlying the first cell fate decision, direct reprogramming, and 
early trophoblast lineage specification. 
1.4 AIMS OF THE RESEARCH PROJECT 
The placenta is a transient but vital organ mediating a myriad of interactions between 
maternal and embryonic tissues. The cells in the TE lineage are responsible for proper 
implantation, placentation, and the vascular and immunological functions of the placenta. 
However, our understanding of molecular mechanisms essential for placentation and TE 
development remain unclear. We contend that elucidation of mechanisms utilized by key 
TE -specific TFs directing the first cell fate decision as well as maintenance and 
differentiation of TE is prerequisite to improve understanding of early embryonic 
development and will ultimately have a positive impact on pregnancy health. In addition, 
elucidating the mechanisms of TF-mediated trans-differentiation/direct reprogramming of 
ES to TS-like cells can enhance our understanding of basic transcriptional and epigenetic 
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regulation that govern cell fate choice not only during reprogramming but also normal 
placental development. Studies of cell fate change, such as from ES to TS-like cell state 
will enhance clinical applications such as disease modeling, drug screening, and 
regenerative therapies. Using a combination of functional genomics, bioinformatics, and 
mouse genetics, my thesis project has undertaken the following Specific Aims: 
AIM 1. TO DETERMINE THE FUNCTION OF ARID3A IN EARLY EMBRYOGENESIS.  
Arid3a had recently been identified as a member of the ES cell pluripotency network 
(Wang et al., 2006). We found that Arid3a is moderately expressed in resting ES cells, 
whereas its expression is significantly increased upon differentiation. In particular, 
Arid3a is highly expressed in extraembryonic tissues which eventually give rise to the 
placenta, suggesting a putative role in placental development. Consistent with this, prior 
loss-of-function studies of Arid3a in mice revealed a lethal phenotype of null embryos 
prior to E13.5, indicating that it may have an important function during early embryonic 
development (Webb et al., 2011). Thus, we sought to determine if Arid3a contributed to 
the first cell fate decision. We examined the action of Arid3a in TE specification by 
testing whether Arid3a OE-ES cells can establish the TE lineage in vitro and ex vivo. We 
also examined the mechanisms by which Arid3a regulates the first cell fate decision by 
investigating its localization and downstream targets in in vitro model systems. Lastly, 
we determined the functions of Arid3a in placental development in mice, by employing 
loss-of-function studies in conventional KO mice, and in human, via analysis of BMP4-
induced ES to TS-like conversion. These studies constitute Chapters 2 and 3 of the thesis. 
AIM 2. TO EXAMINE MECHANISMS OF TF-MEDIATED REPROGRAMMING OF ES TO TS-
LIKE CELLS.  
TS cell-specific reprogramming factors for ES to TS-like cell conversion are well 
established as being instrumental in trophoblast differentiation and placental development 
in vivo. However, their mechanisms of gene regulation during the reprogramming are 
heretofore uncharacterized. Thus, we used three TS cell-specific reprogramming factors, 
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Cdx2, Arid3a, and Gata3, consequently designated as “CAG factors” to elucidate the 
mechanisms of TF-mediated reprogramming of ES towards TS-like cells. By examining 
global mRNA expression changes via RNA-seq, the dynamics of target occupancy 
utilization via ChIP-seq, and changes in chromatin landscapes via ATAC-seq, we 
elucidated a novel “two-step, repression and activation” mechanisms for reprogramming 
of ES to TS-like cells using CAG factors. These studies are presented in Chapter 4 of this 
dissertation. 
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CHAPTER 2: ARID3A IS ESSENTIAL FOR EXECUTION OF THE 
FIRST CELL FATE DECISION VIA DIRECT EMBRYONIC AND 
EXTREMBRYONIC TRANSCRIPTIONAL REGULATION 
2.1 INTRODUCTION 
Transformation of a totipotent zygote into a multilineage blastocyst encompasses a series 
of cellular, morphological, and molecular events required for implantation and 
development into an offspring (Zernicka-Goetz et al., 2009). Three distinct cellular 
lineages—the trophectoderm (TE), the epiblast, and the primitive endoderm—comprise 
the early developing embryo. Two sequential cell fate decisions during blastocyst 
formation are required to establish these lineages. The first cell fate decision, occurring at 
the 16- to 32-cell stage, leads to segregation of the TE and inner cell mass (ICM). The TE 
is required for implantation into the uterus and formation of the placenta, whereas the 
cells in the ICM are pluripotent and have the capacity to give rise to all tissues and organs 
in the body (Niwa, 2007). The second cell fate decision controls division of the ICM into 
the epiblast and the primitive endoderm. 
Since embryonic stem (ES) cells are derived from the ICM (Evans and Kaufman, 
1981), intensive studies have identified crucial ES cell ‘‘core’’ transcription factors (TFs) 
such as Oct4, Sox2, and Nanog that are central to the construction of a sophisticated 
transcriptional regulatory circuit termed the ‘‘core pluripotency network.’’ TFs within the 
circuitry work in concert to allow ES cells to self-renew while maintaining pluripotency, 
primarily by activating pluripotency-associated genes and repressing lineage-specific 
TFs(Kim et al., 2008). In contrast, only a few TFs required for TE specification have 
been identified, and much less is understood as to how they orchestrate the segregation of 
the ICM and TE during the first cell fate decision(Zernicka-Goetz et al., 2009). The first 
Reproduced in part from Catherine Rhee, Bum-Kyu Lee, Samuel Beck, Azeen Anjum, Kendra R. 
Cook, Melissa Popowski, Haley O. Tucker, and Jonghwan Kim(2014). Arid3a is essential to execution 
of the first cell fate decision via direct embryonic and extraembryonic transcriptional regulation. Genes 
Dev. 28(20):2219-2232. (Contributions: C.R., H.O.T., and J.K designed and analyzed the experiments. 
C.R., B.L, and S.B performed data analysis. C.R., H.O.T., and J.K wrote the manuscript with input 
from other authors.) Appropriate permission has been granted by the publisher. 
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cell fate can be divided into four phases: specification, commitment, maintenance, and 
differentiation (Nishioka et al., 2008; Pfeffer and Pearton, 2012). The current consensus 
suggests that specification of the first cell fate, which occurs prior to implantation, is 
activated by the Hippo signaling pathway (Nishioka et al., 2009). Nuclear localization of 
Yap following Hippo repression by Notch in ‘‘outer’’ cells results in the activation of 
critical TE gene expression through interaction with Tead4 (Rayon et al., 2014). This 
leads to sustained and restricted expression of Caudal-type homeobox 2 (Cdx2) and 
initiation of the commitment stage of the first cell fate decision. Cdx2 is broadly 
expressed during preimplantation development (eight- to 16-cell stage) but becomes 
restricted to the outer cells of the TE during blastocyst formation (Dietrich and Hiiragi, 
2007). Cdx2
-/-
 embryos develop to the blastocyst stage but fail to maintain their 
morphology and do not implant (Strumpf et al., 2005). Oct4 is essential for establishing 
embryonic pluripotency (Nichols et al., 1998; Strumpf et al., 2005) and, while broadly 
expressed at the same stages, becomes restricted to the ICM (Dietrich and Hiiragi, 2007). 
Accordingly, Oct4
-/-
 embryos fail to establish a functional ICM (Nichols et al., 1998). 
Studies in both preimplantation embryos and ES cells have established an 
antagonistic relationship between Cdx2 and Oct4 during TE commitment. Knockout or 
knockdown of Cdx2 permits expression of Oct4 in the TE lineage (Strumpf et al., 2005; 
Wu et al., 2010), whereas overexpression (OE) of Cdx2 or knockdown of Oct4 in ES 
cells induces TE differentiation (Niwa et al., 2005). Similarly, OE of Cdx2 or the 
additional TE-restricted TF Gata3 or Tcfap2c promotes transition of ES cells into 
trophoblast stem (TS)-like cells, which are similar to an in vitro counterpart of TE 
derived from preimplantation embryos (Kuckenberg et al., 2010; Ralston et al., 2010). In 
contrast, OE of Oct4 in TS cells promotes an ES cell-like fate (Wu et al., 2011). Several 
factors preferentially expressed in the TE (e.g., Cdx2, Gata3, and Tcfap2c) are involved 
in self-renewal of TS cells (Auman et al., 2002; Chawengsaksophak et al., 1997; Ralston 
et al., 2010). Although the antagonistic regulatory mechanism between Cdx2 and Oct4 
has been widely accepted from results obtained from mouse ES cells, whether they 
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directly repress each other remains controversial (Nishiyama et al., 2009; Niwa et al., 
2005). 
Most TFs within the pluripotency network of ES cells are coordinately down-
regulated upon exit from the self-renewal program, with only a few factors up-regulated. 
AT-rich interactive domain 3a (Arid3a)/Bright/Dril1 is one such pluripotency network 
factor whose modest expression in self-renewing ES cells is dramatically up-regulated 
upon differentiation (Wang et al., 2006). Arid3a, the founding member of the ARID 
family of TFs, has been characterized as a transactivator of both B lymphocyte 
development and cell cycle progression (Herrscher et al., 1995). Loss-of-function studies 
revealed that >98% of Arid3a
-/- 
mice die prior to embryonic day 11.5 (E11.5) (Webb et 
al., 2011), suggesting a potential role in embryonic development. A recent follow-up 
study showed that singular loss of Arid3a is sufficient for reprogramming as well as 
enhancement of standard four-factor reprogramming of mouse embryonic fibroblasts 
(MEFs) to fully induced pluripotent stem cells (Popowski et al., 2014; Takahashi and 
Yamanaka, 2006). That Arid3a is expressed highly in extraembryonic trophoblast 
lineages that give rise to the placenta (Wu et al., 2009) led us to examine its function in 
ES cells and TE lineage commitment and differentiation. 
Here, we present evidence that Arid3a is a critical transcriptional regulator of ES to 
TS-like cell trans-differentiation and plays an important role in the commitment and 
differentiation of TE rather than its specification. Induction of Arid3a in ES cells or bona 
fide blastula-derived TS cells triggers the TE-specific gene expression program and 
differentiation toward subsequent trophoblastic lineages, whereas knockdown of Arid3a 
compromises differentiation of ES cells. When injected into four- to eight- cell stage 
embryos, Arid3a OE-generated TS-like cells adopt an outside cell fate, synonymous with 
commitment to the TE lineage. Intersection of global gene expression, genome-wide 
target mapping, and cellular localization studies revealed that, upon nuclear upregulation, 
Arid3a acts both directly upstream of and parallel to Cdx2 to activate key TE-specific 
genes while directly repressing regulators of ES cell pluripotency, including Oct4 and 
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Nanog. Arid3a and histone deacetylases 1/2 (HDAC1/2) associate at the protein level and 
selectively co-occupy regulatory regions of pluripotent genes, suggesting a mechanism 
by which differential Arid3a complexes contribute to execution of the first cell fate 
decision. 
2.2 MATERIALS AND METHODS 
Cell culture and stable cell lines 
Mouse J1 ES cells were maintained in DMEM (Dulbecco’s modified Eagle’s medium) 
supplemented with 18% fetal bovine serum (FBS), 2 mM L-glutamine, 100 mM 
nonessential amino acid, nucleoside mix (100X stock; Sigma), 100 µM β-
mercaptoethanol, 1000 U/mL recombinant LIF (Chemicon), and 50 U/mL 
penicillin/streptomycin. ES cells were cultured in 0.1% gelatin-coated dishes. Mouse TS 
cells were maintained at a ratio of 3:7 of TS medium to MEF-conditioned TS medium 
with 25 ng/mL Fgf4 and 1 µg/mL heparin. The TS medium was RPMI 1640 (Gibco) 
supplemented with 20% FBS, 100 µM β-mercaptoethanol, 2mM L-glutamine, 
1mMsodium pyruvate, 50 U/mL penicillin, and 50 mg/mL streptomycin. The MEF-
conditioned medium was TS medium conditioned by MEF cells. Mitomycin-treated MEF 
cells were cultured in TS medium for 3 d. The medium was collected every 3 d for three 
times. 293Tcells were maintained in DMEM supplemented with 10% FBS, 2mML-
glutamine, and 50 U/mL penicillin/streptomycin. All cells were incubated at 37°C and 
5% CO2. 
Lentiviral production and infection 
293T cells were plated at ~6 x 10
6
 cells per 100-mm dish and incubated overnight. Cells 
were transfected with 6 µg of pLKO.1 shRNA vector (Sigma) (Appendix) with 4 µg of 
pCMV-Δ8.9 and 2 µg of VSVG helper plasmids using Fugene (Promega), according to 
the manufacturer’s instructions. After 15 h, 293T medium was replaced with ES medium. 
Two days following transfection, the supernatants containing viral particles were 
collected and filtered through 0.45-µm pore size cellulose acetate filters. The cells, which 
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would be infected, were plated at ~1 X 10
6
 cells per six-well plate with virus-containing 
supernatant supplemented with polybrene (Millipore). 
Quantitative gene expression analysis 
Total RNA was isolated from cultured cells using the RNeasy plus minikit (Qiagen). 
cDNA synthesis was performed with qScript cDNA supermix (Quanta). RT-qPCRs were 
performed using PerfeCTa SYBR Green FastMix (Quanta) with 1 µL of 20X-diluted 
cDNA generated from 500 ng of total RNA. RTqPCR primers were designed to amplify 
the junction between two exons using primer 3 (Koressaar and Remm, 2007). ChIP-
qPCR primers were designed to amplify ~100-base-pair (bp) regions centered on the 
putative binding sites. Primer sequences for qPCR are listed in Appendix. CT values 
were normalized against Gapdh for gene expression and compared with Gfi1b_proximal 
promoter binding (negative control) for ChIP enrichment. 
Microarrays and gene expression analysis 
Affymetrix GeneChip mouse genome 430A 2.0 arrays were used for gene expression 
profiles. cDNA synthesis, labeling, hybridization, washing, and scanning were performed 
by the Microarray Core Facility at the Dana Farber Cancer Institutes (DFCI). Expression 
data were normalized using a robust multiple array (RMA). 
ChIP-seq 
ChIP assays were done with ES cell lines expressing BirA only (reference) or both BirA 
and biotin-tagged proteins (samples) as previously described (Kim et al., 2008) using 
streptavidin magnetic particles (Roche). ChIP-seq libraries were generated using ChIP-
seq library prep kits (New England Biolabs) according to the manufacturer’s instructions. 
ChIP-seq libraries were sequenced using an Illumina HiSeq 2500 at the Genomic 
Sequencing and Analysis Facility (GSAF) of The University of Texas at Austin. Raw and 
processed microarrays and ChIP-seq data have been deposited at the public server Gene 
Expression Omnibus (GEO) under accession number GSE56877. 
Immunofluorescence 
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Glass coverslips were affixed to the bottom of six-well plates followed by 0.1% gelatin 
coating. The cells were plated at high density and grown for 1–3 d at 37°C. Slides were 
incubated in 4% paraformaldehyde (in PBS) for 15 min at room temperature followed by 
5% Triton X-100 (in PBS) incubation for 10 min at room temperature. Slides were then 
incubated in blocking solution (3% BSA + 1% normal horse serum in PBS) for 1 h at 
room temperature, primary antibody solution (1:200 dilution) for 1 h at room 
temperature, and secondary antibody conjugated to Alexa Fluor 594 or Alexa Flour 488 
dyes (1:1000 dilution) for 1 h in the dark at room temperature. Last, the glass coverslips 
were dried, affixed to slides using mounting solution, and imaged on a Zeiss 710 laser 
scanning confocal and structured illumination microscope. 
Embryo chimeras 
Host embryos were obtained from B6D2F1 mice and collected at the two-cell stage. 
Approximately 10 ES, Arid3a-overexpressing, or Cdx2-overexpressing cells expressing 
ZsGreen (pEF1a-IRES-ZsGreen1, Clontech) were injected into four- to eight-cell stage 
embryos. After injection, the embryos were cultured in vitro in KSOM+AA (Millipore). 
Images were collected at E3.5. 
Generation of stable cell lines 
Arid3a cDNA was amplified by PCR using a Arid3a mouse cDNA clones (Origene, 
MC205205) as a template and then cloned in to the pEF1α-FLBIO vector (Wang et al., 
2006). Primer sequences for PCR are listed in Appendix. The Arid3a-containing vector 
was transfected into BirA expressing ES cells by electroporation. The positive biotin-
tagged Arid3a OE stable cells were picked and maintained under the same ES media 
described above with puromycin (Invitrogen) and neomycin (Gibco). Ectopic expression 
levels were measured by RT-qPCR and Western blotting using anti-streptavidin-HRP 
(Invitrogen) and anti-Arid3a (Webb et al., 2011). 
Alkaline phosphatase (AP) staining 
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AP staining was performed with an Alkaline Phosphatase Detection Kit (Millipore) 
according to the manufacturer’s protocol. Cells were imaged using an inverted 
microscope (Zeiss).  
Cell growth rate assay 
Cell growth rate assays were performed with the Cell Counting Kit-8 (Dojindo) 
according to the manufacturer’s protocol. The absorbance was measured at 490nm using 
a micro-titer plate reader. 
Cell cycle analysis 
Approximately 1X10
6
 cells were harvested after washing with PBS. The harvested cells 
were fixed in ice cold ethanol and incubated at 4°C overnight. Fixed cells were washed 
with PBS and then stained with propidium iodide in a solution containing RNase A. 
Analysis was performed on a FACSCalibur Flow Cytometer (Becton Dickinson). 
Gene Ontology (GO) analysis 
DAVID 6.7 (Huang da et al., 2009) was used for differentially expressed genes from 
expression profile data, and Genomic Regions Enrichment of Annotation Tool (GREAT) 
(McLean et al., 2010) was used for ChIP-seq data. 
Antibodies 
anti-Arid3a (1:5000;(Webb et al., 2011)), anti-Oct3/4 (1:1000, SC-5279, Santa Cruz), 
anti-Sox2 (1:1000, SC-17320, Santa Cruz), anti-Nanog (1:1000, ab80892, Abcam), anti-
β-actin (1:10000, ab20272, Abcam), anti-HDAC1 (1:1000, ab7028, Abcam), anti-
HDAC2 (1:1000, #5113, Cell Signaling), anti-Cdx2 (1:1000, CDX2-88, Biogenex), anti-
Gata3 (1:1000, SC-9009, Santa Cruz), anti-Tead4 (1:1000, ab58310, Abcam), and anti-
Yap1 (1:1000, SC-101199, Santa Cruz). 
Western blotting 
Proteins were lysed from cultured cells using RIPA Lysis and Extraction Buffer (G-
Biosciences) supplemented with protease inhibitor cocktail (Roche). Cell lysates were 
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separated by electrophoresis on 4-20% gradient acrylamide gels and transferred to PVDF 
membranes. The blots were blocked with TBS-T (20mM Tris-HCl, pH 7.6, 136mM 
NaCl, and 0.1% Tween-20) containing 5% skim milk for an hour and then incubated with 
primary antibody solution at 4°C overnight. After washing with TBS-T, the membranes 
were incubated with HRP-conjugated secondary antibodies for 1 hr at room temperature 
(RT). Then the membrane was developed with ECL reagents (GE Healthcare).  
Whole-mount RNA in situ hybridization 
RNA in situ hybridization was carried out as previously described (Ai et al., 2007). 
Staining reactions were carried out for 2-72 hrs. The Arid3a antisense probe was a 390b 
mouse Arid3a fragment generated from a fragment spanning exons 3 and 4 cloned in 
pGEM-Teasy (Invitrogen) in the T7/sense orientation using primers listed in Appendix. 
Whole mount embryo staining 
Embryos were washed with PBS, followed by fixation in 4% PFA in PBS for 15 minutes 
at RT. Then, the embryos were rinsed briefly in PBS+0.2% goat serum (PBSS) at RT for 
three times. Next, the embryos were permeabilized with 0.2% Triton X-100 in PBS for 
20 minutes at RT, followed by washing in PBSS for 5 minutes at RT. Permeabilized 
embryos were blocked with 0.1% BSA+2% goat serum in PBS (blocking solution) for 
1hour at RT, primary antibody solution (1:200 dilution) for overnight at 4°C, and 
secondary antibody conjugated to Alexa Fluor 594 or Alexa Flour 488 dyes (1:1000 
dilution) with DAPI (1:1000 dilution) for 1 hour in the dark at RT. Lastly, the embryos 
were washed three times with PBS. In the last washing, the embryos were moved to 
slides and imaged on a Zeiss 710 Laser Scanning Confocal & SIM microscope.  
Immunohistochemistry (IHC) 
Preparation and fixation of mouse placentas (C57BL/6) at E11.5 were carried out as 
previously described (Joyner and Wall 2008). Sectioning was done at histology core, the 
University of Texas at MD Anderson Smithville. Antibodies used for staining were anti-
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Arid3a (1:5000;(Webb et al., 2011)), anti-Proliferin (SC-47347, Santa Cruz), and anti-
Tpbpa (ab104401, Abcam).  
Animals 
All housing, husbandry, and experimental procedures with Arid3a knockout and control 
mice were approved by the Institutional Animal Care and Use Committees at The 
University of Texas at Austin. The generation of Arid3a
-/-
 mice has been previously 
described (Webb et al., 2011). Mice used in for placental collection and IHC were PCR 
genotyped using embryo tail genomic DNA.  
Immunoprecipitation (IP)  
One-step affinity purification with streptavidin-agarose bead (Invitrogen) using ~2 x 10
7
 
cells from ES cell lines expressing BirA only or BirA with biotin-tagged proteins was 
performed as previously described (Kim et al., 2010). The final pulled-down proteins 
were eluted in Laemmli buffer prior to Western blotting. 
Principal component analysis (PCA) 
PCA analysis was performed using published expression profiles of TS and differentiated 
TS cells (Kidder and Palmer, 2010) with those of our Arid3a OE cell lines. Common 
probe sets from different Affymetrix array platforms were extracted, followed by 
normalization of the probe sets using Robust Multi-array Average (RMA) analysis from 
Bioconductor. PCA was performed using excel add-ins PCA analysis program, multibase 
2015 (http://www.numericaldynamics.com/).  
Identification of ChIP-sequencing peaks 
FASTAQ files were aligned to mouse genome (mm9, NCBI Build 37) using a Burruws-
Wheeler Aligner (BWA) allowing up to two mismatches (Li and Durbin, 2009). For the 
identification of transcription factor (TF) binding sites, model-based analysis with the 
ChIP-seq (MACS) peak caller (Zhang et al., 2008) was used with a default setting. The 
ChIP-seq signals resulting from BirA-only expressing ES cells were subtracted to remove 
background noise for Arid3a OE cells. Genes occupied by TFs within a 10Kb window 
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(from 8Kb upstream to 2Kb downstream of TSS were considered as target genes and 
used for subsequent analyses.  
Correlation map 
Common binding sites of TFs indicated in Figure 2.14A were identified by peak calling 
with an overlap analysis. The binding sites of two TFs were calculated for with a paired-
end Pearson correlation coefficient. 
Motif analysis 
Motif searches were performed with motif-based sequence analysis tools (Bailey et al., 
2009). Motif similarities were calculated using TOMTOM (Gupta et al., 2007).  
Public data sets used 
Gene expression data sets used for the analyses shown in Figure 2.5,2.15G were obtained 
from the Gene Expression Omnibus (GEO) database under the accession numbers of 
GSE 12986 (Cdx2 OE and Gata3 OE cells), GSE 3766 (TS cells), GSE 2204 (XEN 
cells), GSE 3729 (ES cells), GSE 18507 (TS cell differentiation), and GSE20177 (TS and 
ES cells). ChIP-sequencing data sets used for the analyses shown in 13 were obtained 
from GSE 11431 (E2F1 and n-Myc), GSE 11724 (Nanog and Sox2), GSE 44288 (Oct4), 
GSE 13084 (Ezh2), GSE 26680 (Ring1b), GSE 18776 (Suz12), and GSE 16375 (Cdx2). 
2.3 RESULTS 
Arid3a is dispensable for mouse ES cell self-renewal but critical for normal 
differentiation 
In order to elucidate the function of Arid3a in self-renewal and differentiation, we first 
performed a shRNA-based knockdown of Arid3a in the mouse ES cell line J1. We 
obtained >75% knockdown efficiency at both the protein and mRNA levels (Figure 
2.1A,B). Arid3a-deficient cells displayed normal ES cell morphology as well as alkaline 
phosphatase (AP) activity and proliferation rates comparable with control cells (Figure 
2.1C,D). While knockdown of Arid3a resulted in modest up-regulation of mRNA levels 
of previously established ES cell core pluripotency factors, including Oct4, Sox2, and 
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Nanog (Figure 2.1B), we observed no significant changes in the protein levels of these 
factors (Figure 2.1A). These data indicate that Arid3a is dispensable for self-renewal of 
ES cells.  
Unlike the majority of TFs comprising the ES cell pluripotency network, Arid3a is 
moderately expressed in undifferentiated ES cells but significantly induced upon 
differentiation (Figure 2.2A). To test the potential function of Arid3a during 
differentiation, we cultured Arid3a knockdown ES cells and normal ES cells in 
differentiation medium (leukemia inhibitory factor [LIF] withdrawal). While control ES 
Figure 2.1 Arid3a is dispensable for self-renewal of ES cells. (A) Protein levels of the pluripotency-associated 
TFs, Oct4, Sox2, and Nanog, following Arid3a KD as measured by Western blotting. β-actin is the loading 
control. (B) Arid3a KD (gray) in ES cells leads to modest induction of pluripotency-associated TF expression as 
determined by RT-qPCR. The data are plotted relative to corresponding expression levels of control ES cells 
(white). (C) ES cell morphology upon KD of Arid3a. Arid3a KD cells were plated at clonal density, cultured for 
5 days, and stained for alkaline phosphatase (AP). (D) Comparison of growth rates of Arid3a KD cells with 
normal ES cells under LIF+ and LIF- conditions. 
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cells showed differentiated morphology with reduced rates of growth, Arid3a-deficient 
ES cells maintained undifferentiated cell morphology for about five additional days, with 
proliferation rates similar to those of control ES cells under normal culture conditions 
with LIF (Figure 2.1D,2.2B). The results suggested that either Arid3adeficient ES cells 
are less dependent on LIF, or the cells have impaired differentiation potential. However, 
after prolonged culture in the absence of LIF, we began to observe differentiated 
morphology of Arid3a-deficient cells (Figure 2.2B), suggesting that its loss delayed 
normal ES cell differentiation. Consistent with this, we observed delayed induction of 
lineage-specific marker genes such as Brachyury (mesoderm), Gata6 and Sox17 
(endoderm), and Cdx2 and Gata3 (TE) as well as delayed down-regulation of ES cell 
core factors (Figure 2.2C,D). Notably, the most significantly affected genes upon 
knockdown of Arid3a were TE markers (Figure 2.2C), suggesting that Arid3a may play a 
role in TE differentiation. We confirmed these results in an independent ES cell line 
(E14) and by using a shRNA targeted to the Arid3a 3’ untranslated region (UTR) (Figure 
2.2D-H). The delayed differentiation observed upon knockdown of Arid3a was 
successfully rescued by OE of shRNA-resistant Arid3a (Figure 2.2G,H). 
Induction of Arid3a in ES cells promotes TE differentiation 
The results from knockdown of Arid3a suggested that the reciprocal action, OE of 
Arid3a, might promote ES cells to differentiate even in the presence of LIF. To examine 
this possibility, we generated a pool of Arid3a-overxpressing ES cells (Arid3a OE-Pool) 
and, from this, multiple clones with different levels of ectopic Arid3a expression 
(representative clones are shown in Figure 2.3A,B). Whereas clones expressing Arid3a 
modestly above endogenous levels (e.g., Arid3a OE-Low; approximately two-fold) 
displayed normal ES cell morphology (Figure 2.3A,B), clones with ~20-fold OE (e.g., 
Arid3a OE-High) displayed primarily differentiated phenotypes (flattened epithelial-like 
morphology) with weak AP activity (Figure 2.3C,D). Arid3a OE-High cells exhibited 
significantly slower proliferative rates than normal ES cells (Figure 2.3E). Subsequent 
cell cycle analysis confirmed that Arid3a OE-High cells were reduced in actively  
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Figure 2.2 Arid3a is critical in ES cell differentiation. (A) Reciprocal expression levels of Arid3a (black) and 
Oct4 (green) upon differentiation of ES cells as determined by RT-qPCR (top panel) and Western blotting. (B) 
ES cell morphologies of control ES cells and Arid3a KD cells upon LIF withdrawal. (C) Expression analysis 
of lineages and pluripotency-associated genes (brown, mesoendoderm; orange, ectoderm; red, trophectoderm; 
blue, endoderm; purple, mesoderm; and green, pluripotency-associated) by RT-qPCR in control (gray) and 
Arid3a KD ES cells (white) following removal of LIF. (D) Up-regulation of expression levels of TE lineage-
specific transcripts is delayed in Arid3a KD cells (red) relative to control ES cells (black) following removal 
of LIF. (E) Cell morphologies of control ES cells and Arid3a KD cells upon LIF withdrawal, passage 2. (F) 
Expression analysis of lineages and pluripotency-associated genes in control (white) and Arid3a KD ES cells 
(gray) following removal of LIF. (G) Comparison of cell morphologies of control ES, Arid3a KD (targeting 
3’UTR), and Arid3a OE followed by Arid3a KD (rescued clone) cells upon LIF withdrawal, passage 2. (H) 
Expression analysis of lineage- and pluripotency-associated genes by RT-qPCR in control ES (dark gray), 
Arid3a KD ES (light gray), and Arid3a OE followed by Arid3a KD (rescued, white) cells upon removal of 
LIF, relative to normal ES cells. Error bars depict standard deviations of biological triplicates. 
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Figure 2.3 Induction of Arid3a in ES cells promotes TE differentiation. (A) Expression levels of Arid3a 
as determined by RT-qPCR in ten different Arid3a overexpressing (OE) clones and Arid3a OE-Pool. 
Clones expressing different levels of Arid3a are indicated as different numbers, ranked from 1 to 10 
(Low to High). The data are plotted relative to corresponding expression levels of Arid3a in control ES 
cells (top panel). Protein levels of Arid3a in representative Arid3a OE cells as measured by Western 
blotting. β-actin is the loading control (bottom panel). (B) Cell morphologies of Arid3a OE ES cell 
clones expressing different levels of Arid3a. (C) ES cell morphology upon OE of Arid3a. Arid3a OE 
cells were plated at clonal density, cultured for 5 days, and stained for AP. (D) Expression analysis of 
lineage markers by RT-qPCR in Arid3a OE-Pool (gray) and -High (white) cells. The data are plotted 
relative to corresponding expression levels of control ES cells. All error bars depict standard deviations 
of biological triplicates. (E) Arid3a OE cells grow slower than control ES cells. Shown are the averages 
of biological triplicates with standard deviations. (F) Cell cycle comparisons of Arid3a OE cell lines 
(Arid3a OE-Pool and -High) with control ES and TS cells. Y-axis, distribution of cell cycle as 
measured by flow cytometry/DNA content. 
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proliferating (S-phase) populations and increased in G2/M-phase populations, which is 
similar to that of TS cells (Figure 2.3F). Expression of a panel of multi-lineage markers 
revealed that many were activated by OE of Arid3a in ES cells, whereas pluripotency-
associated gene levels were reduced (Figure 2.3D,2.4A-C). TE lineage markers such as 
Cdx2, Gata3, Tcfap2c, and Hand1 showed particularly strong up-regulation upon OE of 
Arid3a in both J1 and E14 ES cells (Figure 2.3D,2.4D-F), further indicating a role for 
Arid3a in TE lineage specification.  
Global expression profiles of Arid3a-overexpressing ES cells are similar to those of 
TS cells 
To better understand the global transcriptional impact of Arid3a perturbation in ES cells, 
we compared expression profiles of Arid3a knockdown and Arid3a OE-High cells with 
control ES cells using Affymetrix microarrays. We identified 1842 differentially 
expressed genes, with a cut-off threshold of 1.5-fold in at least one expression profile of 
Arid3a-overexpressing cell lines (Arid3a OE-High and OE-Pool). As expected from the 
data shown in Figure 2.1 and 2.2, gene expression changes upon knockdown of Arid3a 
were not significant compared with the changes upon OE of Arid3a (Figure 2.5A). 
A prior study revealed that ~50% reduction of Oct4, a master regulator of 
pluripotency, is sufficient to convert ES cells to TS-like cells (Niwa et al., 2000) that 
share many features with authentic TS cells derived from the TE layer of the early stage 
blastocyst. Since OE of Arid3a in ES cells significantly up-regulated many of the same 
TE lineage-specific markers (Figure 2.3D) as knockdown of Oct4, we also compared the 
global expression profiles of Arid3a-overexpressing cell lines with those of TS-like cells 
derived by knockdown of Oct4 in ES cells. We observed highly similar gene expression 
patterns for Arid3a-overexpressing and Oct4 knockdown cells (Figure 2.5A). Consistent 
with the propensity of Arid3a OE to promote TE lineage specification, the up-regulated 
genes upon OE of Arid3a were strongly enriched in gene ontology (GO) terms associated 
with placental and early embryonic development (Figure 2.5B). On the other hand, the 
relatively fewer number of genes down-regulated upon OE of Arid3a were enriched in  
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Figure 2.4. Arid3a plays a role in TE lineage specification. (A) Expression analysis of TE (red) and 
pluripotency-associated (green) genes by RT-qPCR in Arid3a OE cell lines from Figure 2.3B. (B) OE of 
Arid3a reduces levels of Oct4 and Nanog relative to control ES cells as determined by RT-qPCR. Arid3a 
OE-Pool (gray) and -High (white) cells data are plotted relative to corresponding expression levels of 
control ES cells (red horizontal line). (C) Expression analysis of lineages and pluripotency-associated genes 
(brown, mesoendoderm; orange, ectoderm; red, trophectoderm; blue, endoderm; purple, mesoderm; and 
green, pluripotency-associated) by RT-qPCR in Arid3a OE-Low (gray) and control ES (white) cells. (D) 
Arid3a OE-High cells express more Cdx2 (top) and Gata3 (bottom) relative to control ES cells as 
determined by immunofluorescence (IF). Cells were stained with anti-Arid3a (red, Alex 594), anti-Cdx2 
(green, Alexa 488), anti-Gata3 (green, Alexa 488), and DAPI (blue). (E) Cell morphologies of control and 
Arid3a OE in E14 ES cells. OE of Arid3a in ES cells was done by transient transfection. (F) Expression 
analysis of TE (red) and pluripotency-associated (green) genes by RT-qPCR in Arid3a OE (gray) and 
control (white) in E14 ES cells. Error bars depict standard deviations of biological triplicates. 
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Figure 2.5 Expression profiles of Arid3a OE ES cells are highly similar to those of TS-like cells. (A) An 
unsupervised hierarchical clustering of expression profile of Arid3a OE-High cells. (B,C) Significantly 
enriched terms (biological functions) of up- (B) and down-regulated (C) genes upon OE of Arid3a shown in 
Figure 2.5A by Gene Ontology (GO) analysis. (D,E) Gene set enrichment analysis (GSEA) using ordered 
gene expression levels from Arid3a OE cells over control ES cells (X-axis) with gene sets indicated; top 1% 
of up-regulated genes upon Oct4 KD (204 genes), Cdx2 OE (368 genes), and Gata3 OE (384 genes) in ES 
cells (D). GSEA using TS cell-specific (313 genes), XEN cell-specific (227 genes), and ES cell-specific (218 
genes) gene sets (E). (F) Global expression profiles of Arid3a OE cell lines (Arid3a OE-High and -Pool), TS 
and differentiated TS cells as determined by principal component analysis (PCA). (G) Relative expression of 
top 50 TS cell-specific genes in Arid3a OE-Pool (gray) and -High (white) ES cells. ES cells are used as a 
control. Gene names in red are well-known TE markers. 
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unrelated terms (e.g., RNA processing and cellular metabolic processes) (Figure 2.5C), 
further indicating that the cells are indeed differentiated, particularly toward the TE 
lineage. 
Since ES cells are derived from the ICM of blastocysts, they are generally thought to 
have lost or suppressed the ability to generate TE and trophoblast lineages (Reubinoff et 
al., 2000). Nonetheless, several studies have reported that ES cells can directly trans-
differentiate toward a TS-like cell fate (Kuckenberg et al., 2010; Niwa et al., 2005; 
Ralston et al., 2010). Therefore, we performed gene set enrichment analysis (GSEA) to 
further compare gene expression profiles of Arid3a-overexpressing cells with those of 
published TS-like cells generated by OE of Cdx2 or Gata3 (Ralston et al., 2010) or 
knockdown of Oct4 in ES cells. As shown in Figure 2.5D, each of the three gene sets (top 
1% of genes up-regulated within each of the aforementioned profiles) showed highly 
significant enrichment in genes up-regulated upon OE of Arid3a in ES cells.  
We carried out further GSEA with gene sets generated from the additional published 
expression data sets: TS cell-specific (TS cells vs. ES cells) (Ralston et al., 2010), 
extraembryonic endoderm (XEN) cell-specific (XEN cells vs. ES cells) (Ralston et al., 
2010), and ES cell-specific (ES cells vs. differentiated ES cells) (Hailesellasse Sene et al., 
2007). Consistent with our findings shown in Figure 2.3 and 2.5D, only TS cell-specific 
genes were strongly enriched among the up-regulated genes following OE of Arid3a in 
ES cells (Figure 2.5E). While XEN cell-specific genes showed marginal enrichment, as 
predicted, ES cell-specific genes showed a negative correlation (Figure 2.5E). Principal 
component analysis (PCA) indicated that Arid3a-overexpressing cells fall into a similar 
component with differentiated TS cells (days 10 and 14) (Figure. 5F)(Kidder and Palmer, 
2010). Furthermore, the expression levels of the top 50 most strongly expressed genes in 
TS cells strongly overlapped with those in Arid3a-overexpressing ES cells (Figure 2.5G). 
Collectively, the findings indicate that OE of Arid3a in ES cells results in loss of ES cell 
identity and activation of TS cell-like global gene expression programs. 
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Induction of Arid3a in ES cells results in stable TS-like cells that are capable of 
further differentiation to trophoblast lineages 
Although prior reports showed that OE of TE marker genes (e.g., Cdx2 and Gata3) in ES 
cells induces TE specification, not all of them are capable of producing stable, self-
renewing TS-like cell lines (e.g., Gata3) (Niwa et al., 2005; Ralston et al., 2010). To 
examine whether induction of Arid3a in ES cells can lead to the establishment of stable 
and self-renewing TS-like cells, we adopted Arid3a OE-High cells to an established TS 
medium containing Fgf4 and heparin (Tanaka et al., 1998). After four passages, the cells 
displayed TS cell morphology; i.e., the majority of AP-negative cells gave rise to large 
and flattened cuboidal cells with distinctive boundaries (Figure 2.6A). Moreover, these 
cells expressed multiple TE marker genes at levels similar to their counterparts in 
authentic TS cells derived from the TE of the blastocysts (Figure 2.6B). 
To test the potential of Arid3a-overexpressing cells to drive further TE 
differentiation, Arid3a-overexpressing TS-like cells were induced to differentiate by 
depleting Fgf4 and heparin from the TS culture medium. Within four to five passages, the 
cells appeared largely differentiated, with numerous giant cells present throughout the 
culture (Figure 2.6C). These cells expressed markers for more specialized cells of the TE 
lineage, including Hand1, Id2, Dlx3, Wnt2, and Tpbpa (Figure 2.6D), suggesting that 
Arid3a OE is not only sufficient for establishing the TE-like state but also may be 
required for further differentiation of the TE lineage.  
Both Arid3a and Cdx2 are highly expressed in placenta and extraembryonic tissue 
such as TE (Figure. 6E)(Wheeler et al., 2003). However, analysis of public gene 
expression profiles (Kidder and Palmer, 2010) indicated that Arid3a, but not Cdx2, is 
highly up-regulated in differentiated TS cells (Figure 2.6F). This observation prompted 
us to examine the effect of Arid3a OE on further differentiation of TS cells. Unlike 
control TS cells, TS cells with OE of Arid3a more closely resembled trophoblast giant 
cells (TGCs) even in the presence of Fgf4 and heparin (Figure 2.6G). Accordingly, we 
observed up-regulation of transcripts (Gcm1, Hand1, Id2, Dlx3, Wnt2, and Tpbpa) 
preferentially expressed in TGCs and other more specialized trophoblastic lineages  
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Figure 2.6. Induction of Arid3a converts ES cells to stable TS-like cells that can further differentiate to 
trophoblast lineages. (A) Cell morphologies of control ES and Arid3a OE cells in TS cell derivation 
media. (B) Expression analysis of TE markers (red) by RT-qPCR in Arid3a OE cells in TS cell derivation 
media (gray) and TS cells (white). (C) Cell morphologies of Arid3a OE cell adapted to TS cell derivation 
media (top) followed by removal of Fgf4 and heparin (bottom). Arrows indicated trophoblast giant cells 
(TGCs). (D) Expression analysis of TE and trophoblast markers (red) as determined by RT-qPCR in 
Arid3a OE cells adapted to TS cell media upon withdrawal of Fgf4 and heparin (gray). (E) Left, Arid3a 
and Cdx2 placental transcript levels and right, embryonic and extraembryonic transcript levels in mouse 
(white) and human (gray). Adapted from publicly available data sets in BioGPS (Wu et al. 2009) and 
UniGene (Wheeler et al. 2003), respectively. (F) Relative expression levels of Arid3a (gray) and Cdx2 
(white) under TS cell differentiation culture conditions normalized to their expression levels in TS cells 
prior to differentiation. (G) Cell morphologies of control TS and Arid3a OE TS cells under TS cell 
derivation conditions. Arrows indicate TGCs. (H) Expression analysis of TE differentiation markers (red) 
upon OE of Arid3a in TS cells (gray) and in control TS cells (white) by RT-qPCR. Error bars depict 
standard deviations of biological triplicates. 
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(Figure 2.6H). Thus, in contrast to Cdx2, whose function is restricted to TE lineage 
specification, Arid3a regulates additional trophoblastic pathways beyond TE 
specification, as its OE in TS cells is sufficient to drive further trophoblastic 
differentiation. 
Arid3a and Cdx2 act both independently and in concert to antagonize Oct4 and 
promote ES cells to TS cell trans-differentiation 
To address whether Arid3a participates in the previously proposed Cdx2–Oct4 regulatory 
loop, we compared the consequences of Oct4 knockdown with double knockdown of 
Oct4 + Arid3a or Oct4 + Cdx2 in normal ES cell culture medium. As expected, control 
Oct4 knockdown cells displayed differentiated morphology (Figure 2.7A) with strong up-
regulation of TE markers, including both Cdx2 and Arid3a (data not shown). As with 
Oct4 + Cdx2 double knockdown, double knockdown of Oct4 + Arid3a led to significant 
reduction of the differentiated morphology with less induction of TE markers than control 
Oct4 knockdown cells (Figure 2.7A,B). Immunostaining for Cdx2, Oct4, and Nanog 
confirmed these results (Figure 2.7C), indicating that Arid3a is at least in part involved in 
the Cdx2–Oct4 antagonistic regulatory loop.  
To test whether the involvement of Arid3a in the Cdx2–Oct4 loop is through Cdx2 or 
independent of Cdx2, we performed Arid3a OE in combination with Cdx2 knockdown as 
well as Cdx2 OE in Arid3a knockdown cells. Cdx2 knockdown + Arid3a-overexpressing 
cells and Arid3a knockdown + Cdx2-overexpressing cells both showed differentiated 
morphology with induction of TE markers and repression of pluripotency genes (Figure 
2.7D,E). Thus, Arid3a specifies TE not only through Cdx2 but also independent of Cdx2 
and vice versa. That is, Arid3a and Cdx2 can induce TE-like gene expression programs in 
the absence of each other, although the effect is stronger when both are co-expressed. 
Arid3a gain of function promotes incorporation of ES cells into the TE of developing 
embryos, whereas its loss of function leads to defective placentas To examine the 
potential of Arid3a induction to establish the outside cell fate synonymous with in vivo 
commitment to the TE lineage, we marked Arid3a OE-driven TS-like cells with ZsGreen  
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Figure 2.7. Induction of Arid3a in ES cells gives rise to TS-like cells capable of further differentiation to 
trophoblast lineages. (A) Cell morphologies upon KD of Oct4 and double KD of Oct4+Arid3a or Oct4+Cdx2 
in ES cells under normal ES culture conditions. (B) Expressions of TE (red) and pluripotency-associated 
(green) genes as determined by RT-qPCR following the indicated KD perturbations (KD or double KD; 
dKD) in ES cells (LIF+ conditions). The data are plotted relative to corresponding expression levels in Oct4 
KD cells. (C) IF images of Oct4 KD and Arid3a+Oct4 double KD cells. Cells were stained with anti-Arid3a 
(red, Alexa 594), anti-Cdx2, anti-Oct4, or anti-Nanog (green, Alexa 488), and DAPI (blue). (D) Both Cdx2 
KD+Arid3a OE cells and Arid3a KD+Cdx2 OE cells display differentiated morphology compared to control 
ES, Cdx2 KD, and Arid3a KD cells. (E) Cdx2 KD+Arid3a OE and Arid3a KD+Cdx2 OE cells show 
increased levels of TE markers (red) and decreased levels of pluripotency-associated genes (green) relative to 
those of Cdx2 KD and Arid3a KD cells, respectively. 
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(Figure 2.8A) and injected them into four- to eight-cell stage mouse embryos, with Cdx2-
ZsGreen-overexpressing TS-like cells as a positive control (Lu et al., 2008). At E3.5, 
control ES cells localized within the ICM, whereas Arid3a- and Cdx2-overexpressing 
cells were found exclusively within the TE layer (Figure 2.8B). Arid3a
-/- 
null (knockout)-
derived ES cells (Webb et al., 2011) showed normal ES cell morphology (Figure 2.8C) 
but also failed to localize to the outer TE layer (Figure 2.8B). These along with the above 
in vitro data indicate that gain of function of Arid3a is sufficient to not only direct TE 
fate but induce trans-differentiation of ES cells into TS-like cells with homing properties 
morphologically indistinguishable from bona fide TS cells.  
 
  
Figure 2.8. Arid3a OE promotes incorporation of ES cells into TE of developing embryos. A) Expression 
levels of Arid3a (gray) and Cdx2 (light gray) as determined by RT-qPCR in Arid3a OE (left) and Cdx2 OE 
(right) cells that were used for the embryo injections of Figure 2.8C. Error bars depict standard deviations of 
technical triplicates. (B) Cell morphologies of control ES and Arid3a KO cells. (C) Indicative cells were 
injected into 4- to 8-cell stages of embryos. ZsGreen-Arid3a OE TS-like cells integrate into the TE layer of 
developing embryos. 
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While the cause of death of Arid3a-null embryos was assigned to failed 
erythropoiesis at E11.5 (Webb et al., 2011), potential placental defects were not 
examined. Genotypes of earlier developmental time points revealed loss of knockout 
Mendelian ratios as early as E8.5 (Figure 2.9A). In situ hybridization of Arid3a
+/+ 
embryos at E6.5 indicated strong Arid3a expression in the ectoplacental cone and 
extraembryonic ectoderm of the chorion—sites at which multipotent TS cells reside 
(Figure 2.9B)(Uy et al., 2002). Placental cell types that derive from these regions—TGCs 
and spongiotrophoblasts (SpTs)—strongly expressed Arid3a within their nuclei, as shown 
in E11.5 Arid3a
+/+ 
sections by immunohistochemistry (IHC) (Figure 2.9C,D). IHC of 
E11.5 sections of Arid3a
-/- 
placentas revealed multiple abnormalities. These included (1) 
reduction and disorganization of TGCs and the TGC cell layer, with multiple TGCs 
aberrantly located in the SpT and labyrinth layers; (2) lack of an organized and compact 
SpT layer; (3) reduction in the number of fetal blood vessels in the labyrinth (particularly 
in the central region); and (4) reduction in the number of maternal blood spaces in the 
labyrinth (Figure 2.9D). Thus, Arid3a is a critical regulator for not only TE lineage 
maintenance and differentiation but also proper placenta development. 
Nuclear localization of Arid3a is required for Oct4 repression and TE 
differentiation 
That Arid3a undergoes CRM1-dependent nucleocytoplasmic shuttling in B lymphocytes 
and other somatic cell types (Kim and Tucker, 2006) led us to test its localization in the 
blastocyst and prior to the first segregation by whole-mount embryo staining. In the 
compacted morula stage, Arid3a is expressed in all blastomeres, with localization 
primarily in the cytoplasm (Figure 2.10A). At E.3.5 (early blastocyst), Arid3a localizes 
only within the cytoplasm of the ICM but begins to accumulate within the nucleus of the 
outer cells (Figure 2.10B). Around E.4.5 (late blastocyst stage), Arid3a is highly 
localized in the outer cells of the TE (Figure 2.10A). 
We next examined Arid3a localization relative to Oct4 in normal ES cells, Arid3a-
overexpressing cell lines, and TS cells by immunofluorescence. As shown in Figure 10C,  
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Figure 2.9 Loss of Arid3a leads to defective placentas. (A) Genotypes of offspring from heterozygous 
matings of Arid3a+/- mice. Mendelian frequencies, parentheses; absorptions, slashes. (B) In situ 
hybridization of Arid3+/+ embryos at E6.5 showing Arid3a expression in the ectoplacental cone and 
chorion. EPC, ectoplacental cone; EXE, extraembryonic ectoderm; VE, visceral endoderm. (C) Arid3a is 
strongly expressed within nuclei of trophoblast giant cells (TGCs) and spongiotrophoblasts (SpTs) of E11.5 
Arid3a+/+ placentas. (D) Placentas of E11.5 Arid3a -/- embryos are defective. IHC was performed with 
anti-Proliferin, which marks trophoblast giant cells (TGCs), and anti-Tpbpa, which stains 
Spongiotrophoblasts (SpTs); D, Deciduum. Anti-Arid3a IHC revealed high levels of Arid3a expression in 
Arid3a+/+ TGCs and SpTs. The dotted lines denote the wildtype TGC and SpT expression domains that are 
grossly disorganized in the null placentas. 
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Arid3a, in contrast to Oct4, localized primarily within the cytoplasm of ES and Arid3a 
OE-Low cells. However, the significantly increased levels of Arid3a in OE-High cells led 
to primarily nuclear localization (Figure 2.11A). Notably, differentiated ES cells, which 
have an elevated level of endogenous Arid3a, also showed enhanced nuclear 
accumulation of Arid3a (Figure 2.11B), as did TS cells (Figure 2.11C), which express 
>60-fold higher levels of Arid3a than ES cells (Figure 2.11D). These results indicated 
that Arid3a, when elevated to levels sufficient to initiate trans-differentiation of ES cells 
to TS-like cells (Figure 2.3C,2.6A), accumulates within the nucleus through either 
enhanced nuclear entry or reduced nuclear export. 
Even though Arid3a resides primarily in the cytoplasm in normal or Arid3a OE-Low 
cells, we observed no evidence for Oct4 sequestration within the cytoplasm (Figure 
2.11A). Thus, partitioning of Arid3a and Oct4 into different subcellular compartments in 
ES cells may explain why Arid3a knockdown had no effect on ES cell self-renewal  
Figure 2.10. Arid3a is localized in TE of developing embryo. (A-B) Whole mount embryo staining of 
compacted morula, late blastocyst (A), and early blastocyst stages (B) with anti-Arid3a (red, Alexa 594), 
anti-Oct4 (green, Alexa 488), anti-Cdx2 (green, Alexa 488), and DAPI (blue). Arid3a localizes within all 
blastomeres of the compacted morula and primarily within the outer cells of TE in blastocyst. 
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Figure 2.11. Nuclear localization of Arid3a is required for Oct4 repression and TE differentiation. (A) 
Immunofluorescence (IF) images of control ES, Arid3a OE-Low, and Arid3a OE-High cells. All cells 
were stained with directly conjugated anti-Arid3a (red, Alexa 594) and anti-Oct4 (green, Alexa 488) as 
well as DAPI (blue). Arid3a is primarily cytoplasmic in ES or Arid3a OE-Low cells but shuttles to the 
nuclei of Arid3a OE-High ES cells, resulting in reduced levels of nuclear Oct4. (B) IF images of ES cells 
upon differentiation (LIF-) conditions described in Materials and Methods. Each was stained with anti-
Arid3a (Alexa 594), anti-Oct4 (Alexa 488), and DAPI (blue). (C) IF images of TS cells stained for 
endogenous Arid3a (red, Alexa 594) and DAPI (blue). (D) Relative expression levels of Arid3a and Cdx2 
in bona fide TS cells and ES cells as determined by RT-qPCR. (E) Western blotting showing protein 
levels of Arid3a and Oct4 following Arid3a OE or Oct4 KD in ES cells. β-actin is the loading control. 
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(Figure 2.1A,B). Instead, immunofluorescence detected an opposite shift in nuclear 
intensities of Arid3a and Oct4 on OE of Arid3a (Figure 2.11A,B). This was confirmed 
semi-quantitatively in Western blots of whole-cell extracts; i.e., Oct4 was reduced ~50% 
relative to control ES cells (Figure 2.11E). That Oct4 knockdown up-regulated Arid3a 
levels by approximately eightfold (Figure 2.11E) further suggested that Arid3a and Oct4 
may reciprocally repress one another. 
Cytoplasmic-to-nuclear translocation of Tead4, in addition to gene activation of key 
members of the Hippo pathway, is required for TE specification (Nishioka et al., 2008). 
While mRNA and protein levels of Hippo pathway components were not significantly 
altered (Figure 2.12A,B), we observed enhanced nuclear accumulation of Tead4 in 
Arid3a OE-high cells relative to ES cells (Figure 2.12C). Thus, induction of nuclear 
Arid3a leads to differential Tead4 localization, potentially contributing to ES-to-TS cell 
trans-differentiation. Unlike Tead4, Yap1 remained primarily concentrated in the nucleus 
of ES, TS, and Arid3a-overexpressing cells (Figure 2.12C). 
Target occupancy of Arid3a correlates with Arid3a-mediated gene expression 
Arid3a and Oct4 reciprocally regulate transcript levels of many lineage-specific and 
pluripotency-associated genes (Figure 2.5A). This along with the above results (Figure 
2.11) raised the possibility that Arid3a and Oct4 may share common target genes. We 
first mapped the global target loci of Arid3a using in vivo biotinylation-mediated 
chromatin immunoprecipitation (bioChIP) (Kim et al., 2009) followed by massively 
parallel sequencing. Higher levels of Arid3a OE, as expected from its enhanced nuclear 
localization (Figure 2.11), increased the overall occupancy signals of Arid3a (Figure 
2.13A). The target loci of Arid3a were primarily distributed within intergenic (~42%) and 
promoters (~31%), suggesting that Arid3a regulates both proximal and distal regulatory 
elements (Figure 2.13B).We then compared the target occupancy of Arid3a with the gene 
expression profiles of Arid3a-overexpressing cells using a moving window average 
(window size, 250; bin size, 1). As shown in Figure 2.13C, a large number of genes up-
regulated or down-regulated upon OE of Arid3a are direct transcriptional targets of  
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Figure 2.12. Induction of nuclear Arid3a leads to differential Tead4 localization. (A) Expression 
analysis of key Hippo pathway transcripts by RT-qPCR using control ES cells and Arid3a OE clones 
(Arid3a OE-Low, -High, and –Pool). Error bars depict standard deviations of biological triplicates. (B) 
Protein levels of key regulators of the Hippo pathway (Tead4 and Yap1), following Arid3a OE in ES 
cells as measured by Western blotting. β-actin served as a loading control. (C) Nuclear localization of 
Tead4 (left) but not Yap1 (right) correlates with high Arid3a nuclear levels in TS and Arid3a OE-High 
cells. For IF images, cells were stained with anti-Arid3a (red, Alexa594), anti-Tead4 or anti-Yap1 
(green, Alexa 488), and DAPI (blue). 
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Figure 2.13. Target occupancy of Arid3a correlates with Arid3a-mediated gene expression. (A) A 
Snapshot of a random locus on chromosome 5 illustrating that Arid3a ChIP-seq occupancy signals 
derived from Arid3a OE-High ES cells are stronger than those of Arid3a OE-Low cells. (B) Pie chart 
presenting the distribution of Arid3a peaks. Promoters indicate regions within ±2Kb from the 
transcription start sites (TSS); Intergenic depicts regions other than promoters, exons, or introns. (C) A 
heatmap representation of the expression profile of Arid3a OE cells with representative gene names 
(red: TE-specific genes, green: pluripotency-associated genes). Genes were ordered according to gene 
expression levels in Arid3a OE cells relative to control ES cells. Moving average (window size: 250, 
bin size: 1) was plotted to corresponding Arid3a occupancy signals. (D) A Venn diagram showing 
overlap between Arid3a chromosomal target genes (red) and differentially expressed transcripts in 
Arid3a OE-High ES cells (black, 1.5-fold changes compared to control ES cells). (E) A box plot 
showing the distribution of Arid3a occupancy upon OE of Arid3a in ES cells of (left) the top 500 up-
regulated genes, (middle) 500 genes without significant expression changes, and (right) the top 500 
down-regulated genes. 
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Arid3a (Figure 2.13C-E). Thus, during Arid3a-mediated TE trans-differentiation, Arid3a 
acts as both an activator and a repressor of target gene transcription.  
Arid3a directly activates TE markers and directly represses pluripotency factors 
during ES-to-TS cell trans-differentiation 
Recent target mapping of various TFs in ES cells revealed that clusters of relatively high 
numbers of TFs act together to regulate their common targets (Kim et al., 2008). To gain 
further insight into Arid3a-mediated global gene regulation, we compared its target 
occupancy in Arid3a OE-High ES cells with publicly available ES cell ChIP-seq (ChIP 
combined with deep sequencing) data for the following factors: pluripotency-associated 
TFs (Oct4, Sox2, and Nanog), key components of Polycomb-repressive complex (Ezh2, 
Suz12, and Ring1b), Myc-related (n-Myc and E2f1), and the TE master regulator Cdx2 
(Figure 2.14A). Although Arid3a and Cdx2 have similar consequences on ES-to-TS cell 
trans-differentiation, we found very low accordance in their target sets (Figure 2.14A-C), 
indicating that their underlying TE regulatory mechanisms must differ. Instead, Arid3a 
target loci strongly overlapped with those of pluripotency-associated factors (Figure 
2.14A-D), and Arid3a target genes are highly enriched in the previously defined ES cell 
core module (Figure 2.14E)(Kim et al., 2010). Notably, we observed strong enrichment 
of the Oct4 DNA-binding motif in Arid3a target loci with the perfectly conserved core 
octamer sequence (ATGCAAAT) (Figure 2.14F). Accordingly, Arid3a and Oct4 
occupied the same regulatory regions of numerous pluripotency-associated genes, 
including Oct4 itself and Nanog, whereas TE-specific genes, including Cdx2, Gata3, Id2, 
and Tcfap2c, were singularly occupied by Arid3a (Figure 2.14G,H). Gene ontogeny 
analyses predicted highly significant enrichment of Arid3a targets in signatures 
associated with blastocyst formation, trophectodermal cell differentiation, and early 
embryogenesis (Figure 2.14I,J). We conclude that, in general, the gene targets shared by 
Arid3a and Oct4 are repressed, whereas the targets occupied by only Arid3a are activated 
upon induction of Arid3a in ES cells. 
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Figure 2.14. Arid3a and Oct4 occupy highly similar target loci. (A) Target correlation map of indicated 
TFs illustrating that Arid3a target loci overlap with those of core TFs. (B) Binding positions of Oct4 
(yellow), Nanog (green), and Cdx2 (red) relative to the center of corresponding Arid3a target loci. (C) 
Read-based ChIP-seq signals of Oct4, Nanog, and Cdx2 at the Arid3a target sites (± 5Kb). (D) Venn 
diagram showing that the majority of Oct4 and Arid3a target genes overlap. (E) A box plot showing the 
distribution of Arid3a occupancy signals for the previously defined three pluripotency modules (Core, 
PRC, and Myc) (Kim et al. 2010). (F) Motif analysis of Arid3a and Oct4 target loci indicates that the 
prototypical octamer motif is the most highly enriched DNA binding site for both TFs. (G,H) Snapshots 
of ChIP-seq signal tracts of Oct4 (green) and Arid3a (red) at the regulatory regions of pluripotency-
associated genes (G) and TE markers (H). (I,J) Enriched biological functions (I) and MGI expression 
terms (J) of the top 5,000 strongest Arid3a target peaks by Gene Ontology (GO) analyses. 
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Arid3a represses pluripotency-associated genes by recruiting HDACs 
HDACs have been implicated in numerous transcriptional repression and chromatin 
remodeling contexts as well as in silencing of cell fate decisions (Dovey et al., 2010). 
Recent reports suggested that HDACs are associated with ES cell core factors in a 
complex termed ‘‘NODE’’ for Nanog and Oct4-associated deacetylases (Liang et al., 
2008). Furthermore, a significant number of pluripotency-associated TFs share their 
targets with HDACs (Whyte et al., 2012). Thus, we reasoned that HDACs may 
distinguish Arid3a-mediated repression from Arid3a-mediated activation (Figure 
2.14G,H). Consistent with this hypothesis, we observed strong Arid3a–HDAC1/2 co-
immunoprecipitation (co-IP) in Arid3a OE-High cells (Figure 2.15A). 
Since the levels of HDAC1 and HDAC2 were not elevated by Arid3a OE in ES cells 
(data not shown), we used HDAC1 ChIP to determine whether the target occupancies of 
HDAC1 are altered upon OE of Arid3a. As shown in Figure 2.15B, HDAC1 occupied 
regulatory elements of pluripotency-associated genes more strongly following Arid3a OE 
than in control ES cells, whereas only modest changes were observed in regulatory 
elements of TE-specific genes. In contrast, activation-associated histone acetylation 
marks (AcH3 and AcH4) were significantly enriched at the regulatory regions of TE-
specific marker genes, whereas weaker signals were associated with pluripotency-
associated genes (Figure 2.15C). These data suggested that the repression of 
pluripotency-related genes in Arid3a-overexpressing cells is at least in part mediated by 
the activity of HDAC1 and Arid3a, whereas histone acetyltransferases (HATs) are 
recruited to TE-specific regulatory elements with Arid3a. In further support of this 
notion, target genes co-occupied by both HDAC1 and Arid3a, many of which are ES cell-
specific (Figure 2.15F, top), are strongly repressed upon induction of Arid3a (Figure 
2.15D,F). Conversely, regulatory elements of TE-specific genes that are up-regulated 
upon OE of Arid3a were not co-occupied by HDAC1 and Arid3a (Figure 2.15E). Unique 
targets of HDAC1 were not restricted to either TS cell- or ES cell-specific genes (Figure 
2.15F, bottom). These data along with the co-IP results (Figure 2.15A) indicate that the  
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Figure 2.15. Arid3a recruits HDACs onto loci of pluripotency-associated genes. (A) Immunoprecipitation 
(IP) of Arid3a complexes from control ES cells (Cont) or Arid3a OE-High ES cells (Arid3a). (B) Fold 
enrichments of HDAC1 binding to the regulatory regions of pluripotency-associated genes (red), lineage 
markers (green), and Arid3a (black). (C) Fold enrichments of AcH3 (gray) and AcH4 (light gray) marks at 
the regulatory regions of pluripotency-associated genes (red), lineage markers (green), and Arid3a (black). 
Error bars depict standard deviations of biological triplicates (B,C). Prox, Up, and Dn indicate regions 
proximal, upstream, and downstream, respectively, of the TSS (B,C). (D,E) Snapshots of ChIP-seq signal 
tracts of HDAC1 (blue) and Arid3a (red). (F) GSEA using gene sets of targets in common to HDAC1 and 
Arid3a or unique to HDAC1. (G) Embryonic vs trophoblastic lineage choice depends on differential 
nuclear import and HDAC association of Arid3a. 
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repression of pluripotency-associated genes upon OE of Arid3a is mediated by selective 
recruitment of HDAC1 onto their common cis-regulatory elements. 
2.4 DISCUSSION 
Here we identify Arid3a as a central transcriptional regulator of TE lineage commitment 
and differentiation. Arid3a is highly expressed in vitro in nuclei of TE and TS cells as 
well in vivo in outer cells of early blastocyst and TE-derived placental lineages. OE of 
Arid3a is sufficient to transdifferentiate ES cells into TS-like cells in vitro. When 
transplanted into developing mouse blastocysts ex vivo, Arid3a-driven TS-like cells 
integrate into the TE layer of developing embryos. The induction of Arid3a in TS cells 
leads to further differentiation of TS cells to more specialized trophoblastic lineages—a 
fate not executed by Cdx2. Arid3a acts both directly upstream and independently of Cdx2 
to promote TE pathways while directly repressing Oct4-dependent pluripotency 
pathways. We provide evidence that selective TE versus ES gene regulation is mediated 
epigenetically via differential HDAC recruitment. 
Trans-differentiation of ES cells toward TE lineage via OE of a single TF was 
previously reported for Cdx2 and Gata3 (Niwa et al., 2005; Ralston et al., 2010). 
Although our data on Arid3a show similar consequences on TE fate specification, we 
found that Arid3a and Cdx2 do not appear to share similar regulatory mechanisms. While 
the prior work using Cdx2-inducible ES cells showed exclusive target occupancy of Cdx2 
on TE lineage-specific genes (Nishiyama et al., 2009), our genome-wide mapping 
revealed that Arid3a directly binds to the regulatory elements of both TE-specific factors 
(including Cdx2, Gata3, Tcfap2c, and Id2) and pluripotency-associated genes (such as 
Oct4 and Nanog) during trans-differentiation (Figure 2.13). This differential target gene 
occupancy between Cdx2 and Arid3a is consistent with their phenotypic dissimilarity 
found during the differentiation of TS cells into more specialized trophoblast cells 
(Figure 2.6), further indicating the existence of multiple sub-regulatory networks 
responsible for TE lineage specification or differentiation. 
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Notably, we found that Arid3a directly occupies the regulatory elements of Cdx2 
(Figure 2.14), suggesting that, at least in certain contexts, Arid3a is an upstream regulator 
of this TE ‘‘master’’ regulator. On the other hand, Cdx2 and Arid3a also operate in 
parallel pathways to achieve TE trans-differentiation, as shown by reciprocal knockdown 
and OE analyses of Figure 2.7. It will be of great interest to identify additional key 
regulators of TE lineage specification and elucidate how these regulators are intertwined 
in combination with other co-regulators to coordinate downstream gene expression 
programs during early cell fate decision and eventually placenta development. 
We show TE segregation both in vivo and in cultured ES cells under natural or 
ectopically induced high levels of Arid3a, which the subcellular localization of Arid3a 
correlates strongly with execution of TE fate. Arid3a largely resides in the cytoplasm of 
early blastomeres and the ICM but, by E4.5, undergoes translocation to nuclei of the 
outer TE cells (Figure 2.10,2.11). Similarly, its translocation from self-renewing ES cell 
cytoplasm to the nucleus is required to repress the TE antagonist Oct4 to levels sufficient 
to promote ES-to-TE trans-differentiation and consistent with prior studies (Niwa et al., 
2000). Further supporting our hypothesis, both TS cells and Arid3a OE-derived TS-like 
cells as well as placental TGCs and SpTs displayed primarily nuclear localization of 
Arid3a (Figure 2.9,2.10). Previous studies showed that Arid3a undergoes CRM1-
dependent nucleocytoplasmic shuttling in somatic cell types, but the underlying 
mechanism remains unknown (Kim and Tucker, 2006). A similar mechanism was shown 
to activate Tead4, the well-defined Hippo pathway TF essential for TE specification 
(Nishioka et al., 2008). Accordingly, we observed Tead4 translocation correlated with 
Arid3a nuclear levels (Figure 2.12). An important subject of future study will be to 
determine how the nuclear localization of Arid3a is post-translationally regulated and the 
consequences on its distinct transcriptional programs in ES and TS cells. 
We observed a strong correlation between Arid3abound target genes with transcripts 
deregulated upon Arid3a OE. The general pattern was that upon Arid3a OE, TE factors 
were activated, and pluripotent factors were repressed. A central question raised by our 
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integrative DNA-binding and global gene expression analysis was how Arid3a functions 
as both an activator and a repressor depending on its target genes. The first hint was our 
finding that Arid3a interacts with HDAC1 and HDAC2 at the protein level (Figure 2.15). 
HDACs generally convey repressive function in somatic cells, particularly in the context 
of the NuRD complex. However, recent studies indicate that HDACs are also bound to 
active chromatin in both ES and TS cells (Kidder and Palmer, 2012). In ES cells, HDAC1 
associates with regulatory regions of key TFs implicated in the maintenance of ES cell 
self-renewal (such as Oct4, Sox2, and Nanog), whereas, in TS cells, HDAC1 binds to 
crucial TE genes (including Cdx2, Elf5, and Eomes) (Kidder and Palmer, 2012). Our 
HDAC1 ChIP followed by quantitative PCR (qPCR) analysis indicated that Arid3a OE 
promotes stronger occupancy of HDAC1 onto the regulatory elements of pluripotency-
associated genes without significant occupancy changes at the regulatory elements of TE-
specific genes. Importantly, a high level of Arid3a–HDAC1 co-occupancy is observed at 
pluripotency-associated loci in Arid3a-overexpressing TS-like cells. Perhaps this Arid3a–
HDAC1 interaction alters the activity/specificity of HDAC1, leading to deacetylation of 
pluripotency-associated nucleosomal histone tails (Figure 2.15). Thus, differential co-
occupancy of HDAC1 and Arid3a may be responsible for the repressive role of Arid3a. 
Our results in Figure 14D additionally suggest putative associations of Arid3a and HAT 
for the activation of TE-specific genes. 
While Arid3a can phenocopy, if not surpass, Cdx2 in executing ES-to-TE trans-
differentiation in cultured cells, there is a critical difference in vivo. Cdx2 is critical for 
the first cell fate commitment of the TE, as Cdx2
-/-
 embryos fail to implant (Strumpf et 
al., 2005). However, while fetal death was observed as early as E8.5 (Figure 2.9A), the 
majority of Arid3a-null embryos can implant and develop to as late as E11.5 (Webb et 
al., 2011), albeit with gross defects in placental cellularity and architecture, including 
expression and organization of the direct descendants of TE, TGCs, and SpTs (Figure 
2.9)(Uy et al., 2002). However, in the in vitro context, Arid3a can directly activate Cdx2 
and indirectly activate an arm of the Hippo pathway (shown to be upstream of Cdx2 by 
inducing Tead4 nuclear localization)—events associated previously with the specification 
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phase of the first cell fate. Perhaps, in vitro, the distinction between specification and 
commitment is less strict than in vivo, where these steps are readily distinguished by 
preimplantation and post-implantation. We are currently examining Arid3a
-/- 
preimplantation embryos to better resolve this issue. 
Although not entirely analogous, many of these processes in mice are conserved in 
human placenta development. A notable exception and in support of the possibility that 
Arid3a acts in parallel with Cdx2 is that the reciprocal Cdx2–Oct4 expression patterns 
observed in mice are not conserved in humans (Hay et al., 2004). Further consistent with 
defects in the Arid3a
-/-
 placentas, disruption of the migration of differentiating TGCs can 
result in poorly formed vessels that lead to vascular insufficiency of the placenta and 
fetus, which in turn may result in preeclampsia (Red-Horse et al., 2004). Expression 
profiling of human chorionic trophoblast progenitor cells and primary villous 
trophoblasts identified Arid3a as highly expressed in these lineages (Genbacev et al., 
2011). Human TGCs, which highly express Arid3a (Genbacev et al., 2011), are the first 
cell type to terminally differentiate during embryogenesis and are of vital importance for 
implantation and modulation of the post-implantation placenta (Red-Horse et al., 2004). 
These findings point to potential Arid3a involvement in human placental fate and 
maintenance and suggest that it will be extremely informative to determine Arid3a 
function in both normal and preeclamptic placenta. 
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CHAPTER 3: ARID3A IS REQUIRED FOR MAMMALIAN 
PLACENTA DEVELOPMENT 
3.1 INTRODUCTION 
Two sequential cell fate decisions during blastocyst formation establish three distinct 
cellular lineages—trophectoderm (TE), epiblast, and primitive endoderm (Rossant and 
Tam, 2009; Zernicka-Goetz, 2004). The first cell fate decision in mice and humans 
occurs at the 8- to 16-cell stage and leads to segregation of the inner cell mass (ICM), 
which gives rise to all tissues of the body, and the TE, which is required for implantation 
into the uterus and formation of the placenta (Niwa, 2007). The placenta is essential for 
survival of the mammalian embryo, as it transports nutrients, produces hormones, 
provides structural support within the womb, provides immunological protection, and 
acts as a physiological buffer between the mother and the fetus (Simister and Story, 
1997). Abnormal placental development underlies a wide range of complications during 
pregnancy, including preeclampsia (PE), miscarriage, and predisposition to chronic 
disease in adulthood (Roberts et al., 1989; Suzuki, 2008). PE, a pregnancy-specific 
placental disorder characterized by the development of hypertension during gestation, is a 
major obstetric problem that contributes substantially to maternal and perinatal morbidity 
and mortality worldwide (Ananth et al., 2013). 
While genome-wide analyses have identified genes deregulated in PE, only a few 
transcription factors (TFs) have been shown to be associated with normal TE 
specification and/or human placental differentiation (Hemberger et al., 2010; Martinez-
Fierro et al., 2016). Its strong similarity with human placentation makes the mouse an 
excellent model to elucidate key mechanisms of placental development.  
Our previous studies showed that AT-Rich Interactive Domain 3A (ARID3A) is  
  
Reproduced in part from Catherine Rhee, Melissa Edwards, Christine Dang, June Harris, Mark Brown, 
Jonghwan Kim, and Haley O. Tucker (2016). ARID3A is required for mammalian placenta 
development. Dev Biol. In press. (Contributions: C.R. and H.O.T. designed and analyzed the 
experiments. C.R., M.E., and J.H. performed mouse experiments. C.R., and C.D. performed human iPS 
cell experiments. C.R. and H.O.T. wrote the manuscript with input from other authors) 
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essential for the first cell fate decision (Rhee et al., 2014). We found that overexpression 
(OE) of ARID3A alone is sufficient for trans-differentiation of embryonic stem (ES) cells 
to trophoblast stem (TS)-like cells—the in vitro counterpart of the TE layer of the 
blastocyst. Global expression profiles of ARID3A-OE ES cells and TS cells are highly 
similar. Arid3a-OE ES cells gain the capacity to incorporate into the TE of developing 
embryos—an indication of the development of functional TS cells.  
To gain insight into the role of Arid3a in placentation, we have carried out further in 
vivo analyses in the mouse and in vitro analyses in the human. Our data indicate that 
ARID3A provides an indispensable and conserved function in mammalian placental 
development and may provide a novel diagnostic marker for PE. 
3.2 MATERIALS AND METHODS 
Mouse TS cell culture 
Mouse TS cells were maintained at a ratio of 3:7 of TS medium to MEF-conditioned TS 
medium, supplemented with 25ng/mL Fgf4 and 1ug/mL of Heparin (TS+ medium). TS 
medium is RPMI 1640 (Roswell Park Memorial Institute Medium, Gibco) supplemented 
with 20% FBS, 100uM β-mercaptoethanol, 2mM L-glutamine, 1mM sodium pyruvate, 
penicillin (50U/mL), and streptomycin (50mg/ML). MEF-conditioned medium is TS 
medium conditioned by MEF. MEF were treated with mitomycin, followed by culture for 
9 days with collecting the medium every third days.  
Mouse TS cell in vitro differentiation 
Mouse TS cells were differentiated for four days by withdrawing Fgf4 and Heparin from 
the TS+ medium described above. 
Human iPS cell culture 
Human iPS cells (Yamanaka retrovirus reprogrammed hiPSC, ACS-1023, ATCC) were 
passed for sterility tests, showing negative results for bacterial, fungal, and mycoplasma, 
and STR profile of the cells were confirmed by STR analysis and karyotype by G-
banding (performed by ATCC). The cells were maintained in mTeSR1 media (Stemcell 
technologies). iPS cells were cultured in matrigel (corning) plates. The cells were 
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incubated at 37°C, 5% CO2. For individualization of iPS cells, the cells were detached 
using TrypLE followed by plating with mTESR1 supplemented with Y27632 (ROCK 
inhibitor, Alexis biochemical). 
Human TS-like cell generation 
Human TS-like cells were generated by adding 250ng/mL of BMP4 to human iPS cell 
culture medium as described above for 48 hours. 
Lentiviral production and infection 
293T cells (Sigma) were used to produce lentivirus for shRNA-based KD of ARID3A 
with pCMV-Δ8.9 and VSVG helper plasmids using lipofectamine 3000 (Invitrogen), 
according to the manufacturer’s instructions. After 12 hours, 293T medium was replaced 
with human iPS medium (mTeSR1). 48 hours following transfection, the supernatant-
containing viral particles were filter-collected. 
Immunohistochemistry  
Tissue sections were deparaffinized, permeabilized with 100 ul of 0.1% Tween20, then 
treated with 3% H2O2 to block endogenous peroxidase activity. Antigens were retrieved 
by adding boiling 10 mM citrate buffer (pH 6) and incubating the sections in a 95°C 
water bath for 20 minutes. Slides were then washed with 0.01% Tween20, 1% BSA in 1X 
Dulbecco’s PBS, and blocked with 10% horse serum, 1% BSA in TBS for 1 hour. 
Primary antibody was diluted in TBS + 1% BSA, and slides were incubated at 4°C 
overnight; secondary antibody was diluted in the same manner. Sections were then 
developed using Thermo Scientific Pierce DAB substrate (Fisher Scientific), 
counterstained with Haemotoxylin (Fisher Scientific), mounted with organo-limonene 
mounting media (Sigma-Aldrich), and stained with anti-Arid3a (Webb et al., 2011), anti-
Hand1 (Santa Cruz, sc-9413), anti-Proliferin (Santa Cruz, sc-47347), anti-Pl1 (Santa 
Cruz, sc-376436), anti-Mash2 (GeneTex, GTX60272), anti-Cdx2 (Abcam, ab88129), 
anti-Gcm1 (Thermo Fisher, PA5-46853) antibodies. 
RNA isolation and RT-qPCR 
RNA was isolated using the RNeasy Mini Kit (Qiagen). 500ng RNA was then used to 
synthesize cDNA with qScript cDNA supermix (Quanta). 2uL of 20X diluted cDNA was 
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used per well of a 96-well plate for RT-qPCR analyses performed using SYBR PerfeCta 
SYBR Green fast mix (Quanta). Primers for qPCR were designed to amplify a ~100 base 
pair region containing an overlap of two exons. The Ct values obtained from qPCR were 
normalized against Gapdh expression to determine relative gene expression. 
Immunofluorescence (IF) 
Cells were plated at high density on 6-well plates (Ibidi) and grown for 1-3 days at 37°C. 
Slides were fixed using 4% paraformaldehyde, followed by incubation in 0.5% Triton X-
100 in blocking solution (3% BSA + 1% Normal Horse Serum in PBS). Slides then were 
incubated in Arid3a primary antibody solution (1:200 dilution) overnight at 4°C, and 
secondary Rabbit antibody conjugated to Alexa Flour 594 dyes (1:1000 dilution) for 1 
hour in the dark at room temperature. Lastly, the plates were imaged on a Zeiss 710 Laser 
Scanning Confocal & SIM microscope. Anti-Arid3a affinity purified antibody (Webb et 
al., 2011) was used for staining. 
Weighing and measuring of embryos 
Embryos of Arid3a-/- null C57BL/6 mice (Webb et al., 2011) were obtained from timed 
matings of heterozygous Arid3a breedings and harvested at E10.5-E12.5. The uterine 
horns from the pregnant females were removed and each individual embryo was 
separated from the uterus with fine forceps and scissors before being placed in RPMI 
media. Under a dissecting microscope the yolk sack of each fetus was removed with fine 
forceps while leaving the placenta attached. The fetus and placenta were then flushed 
with 1x PBS prior to being weighed together. Each placenta was then detached from its 
fetus and individually weighed and measured. Weights were determined by subtracting 
the combined fetal and placental weights from those of the placenta. Measurements were 
determined by placing each placenta in a flat dish and taking the average of two 
maximum diameters at 90° angles with a metallic scale graduated in millimeters (mm). 
Numbers of embryos and placentas shown in Figure 2A were used for the measurements 
and statistical analysis shown in Figure 2C and D. All mice were euthanized under the 
guidelines of IACUC protocol (AUP-2015-00195) registered at our institution.  
Semi-quantitative trophoblast giant cell (TGC) assessment  
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Since TGC regional disruption was severe in Arid3a nulls, TGC counting was assessed 
semi-quantitatively by visual inspection in the multiple section images. 
RNA-sequencing analysis 
Placentas of E10.5 and E11.5 Arid3a
+/+
 and Arid3a-/- mice were analyzed by deep 
sequencing, using Illumina HiSeq 2500, paired-end technology. Placentas were removed, 
flash frozen on dry ice, and RNA was harvested using Trizol reagent. Total RNA was 
employed for library preparation using standard Illumina protocols. Once data were 
generated, Illumina software was used for base calling. Sequenced reads were trimmed 
for adaptor sequence, then mapped to mm9 whole genome using tophat. RPKM was 
calculated using ‘cuffdiff’.  Sequencing data are submitted to the NCBI Gene 
Expression Omnibus (GEO) under accession number GSE79638. 
3.3 RESULTS 
Arid3a is highly expressed during mouse and human placentation 
We first analyzed published global expression profiling for each stage of mouse 
embryonic development (Smith et al., 2014). Arid3a expression initiates in the morula, 
then later, becomes highly expressed in extraembryonic components (Figure 3.1A). 
Because a subset of these extraembryonic components are expressed in the placenta, we 
compared the levels of Arid3a with other key placental markers, including Gata3, 
Tfap2c, Hand1, and Id2 in vivo and upon time-course differentiation of TS cells-the in 
vitro counterpart of the TE (Kidder and Palmer, 2010). As shown in Figure 3.1A, both 
Arid3a and these transcripts are highly enriched within extraembryonic components and 
TE. However, other TE markers such as Cdx2, Eomes, Id2, and Hand1, are down-
regulated upon TS differentiation (Figure 3.1B). This suggested that Arid3a differs from 
previously studied TE markers in that it expresses in mouse placentation both in vivo and 
in vitro. 
Similar to the mouse, ARID3A levels in human are the highest in the placenta as 
compared to all other tissues (Li et al., 2013; Rhee et al., 2014)(Figure 3.2A). Analyses of  
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publically available data sets (Mikheev et al., 2008) further revealed that ARID3A is 
highly expressed throughout placental gestation from the 1
st
 to 3
rd
 trimester (Figure 3.2B) 
as well as in human TS-like cells induced from ES cells by BMP4 (Xu et al., 
2002)(Figure 3.2C). Unlike BMP4-induced TS-like cells, neither human ES cell-derived 
endodermal cells (Figure 3.2D) nor embryoid bodies (Figure 3.2E) displayed significant 
induction of human ARID3A. 
Loss of ARID3A during early mouse gestation results in intrauterine growth 
restriction and defects in placental development 
Arid3a
-/-
 null C57BL/6 mice (Webb et al., 2011) were employed to investigate the role of 
Arid3a in early placental development. Breeding heterozygous Arid3a mice resulted in 
non-Mendelian ratios from E10.5-E12.5, with no homozygous mutants obtained at E12.5 
(Figure 3.3A). Since our previous studies (Rhee et al., 2014) detected high ARID3A 
expression in the TE, we carefully examined the gross anatomy of all E10.5 and E11.5 
surviving embryos and placentas from Arid3a mutant heterozygous crosses. Arid3a 
mutants exhibited a range of phenotypes, from indistinguishable, to small, to paler   
Figure 3.1. Arid3a is highly expressed during mouse placentation. (A) Global expression profiling of 
TE markers in early mouse embryonic developmental stages. (B) Expression levels of TE markers 
upon differentiation of mouse TS cells. Differentiation day, d 
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embryos and placentas—further indications of the vasoconstriction characterized 
previously (Webb et al., 2011)( Figure 3.3B,C). 
E10.5 nulls were frequently observed undergoing absorption (data not shown), and 
perhaps the adhesive properties underlying this as yet to be determined phenomenon 
account for their heavier weights relative to E10.5 wild-type (WT) controls (Figure 
3.3C). Mutant placental diameters at E10.5 also significantly exceeded those of WTs but  
Figure 3.2. Arid3a is highly expressed during human placentation. (A) Global expression profiling of 
TE and pluripotency markers in human tissues, including placenta. (B) Absolute expression levels of 
ARID3A in placenta throughout gestation from 1
st
 to 3
rd
 trimester. Two ARID3A values were two 
different human ARID3A probes used in human microarray data. Two values were detected from two 
different regions of sequences within ARID3A coding DNA sequences. (C) Expression levels of TE 
and pluripotency markers upon BMP4-mediated differentiation of human ES and iPS to TS cells. 
Replication, r. (D) Expression levels of ARID3A in human ES cell-derived endoderm cells showing 
that ARID3A level is not altered. (E) Expression levels of ARID3A in human embryoid bodies showing 
that ARID3A level is not significantly altered upon differentiation. 
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were significantly smaller at E11.5 (Figure 3.3D). One explanation for these data was that 
Arid3a-deficient placentas might be undergoing inflammatory-mediated swelling at 
E10.5 followed by apoptotic-mediated atrophy at E11.5 (further addressed below and in 
Figure 3.7A). 
Figure 3.3. Arid3a KO in mouse embryos results in defects in placental development. (A) The numbers 
of viable placentas and embryos at E10.5, E11.5 and E12.5. Homozygous lethality of Arid3a null 
embryos was observed at E12.5. (B) Representative examples of Arid3a KO and WT mouse embryos 
and placentas at E10.5 and E11.5. (C) Weight comparisons among WT, heterozygous and null embryos 
and placentas. (D) Placental diameter comparisons among WT, heterozygous and null placentas. 
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Arid3a mutant placentas have structural defects in placental organization 
We first addressed abnormal size and weight mutant phenotypes by hematoxylin and 
eosin (H&E) staining. As shown in Figure 3.4, both E10.5 and E11.5 mutant placentas 
displayed abnormal organization of the junctional zone, disruption of both trophoblast 
giant cell (TGC) and spongiotrophoblast (SpT) layers, as well as an anomalous labyrinth 
layer. Consistent with these observations, immunohistochemistry (IHC) at E10.5 and 
E11.5 revealed that ARID3A protein was predominantly localized within nuclei of TGCs 
in WTs (Figure 3.4B). Additionally, we tested TGC markers at E9.5. Initially, TGCs 
were present in E9.5 Arid3a null placentas, but then are lost as placentas further 
developed (Figure 3.5A). Quantification indicated that the TGC densities within the 
junctional zone were also significantly reduced in Arid3a KO placentas (Figure 3.5B).  
Next we examined the expression of HAND1, PROLIFERIN, and PLACENTAL 
LACTOGEN (PL1), which are required for the differentiation of cellular subtypes 
expressed in the TGC layer of the junctional zones (Scott et al., 2000)( Figure 3.4C-E). 
While HAND1 expression was evident in E10.5 WT placentas, mutants showed 
significantly reduced staining around the junctional zones (Figure 3.4C). Levels of 
PROLIFERIN and PL1 were highly disrupted in null placentas (Figure 3.4D,E). 
Consistent with disruption of the SpT layer, expression levels of SpT markers such as 
ASCL2 and CDX2, were significantly reduced at E11.5, as confirmed by RT-qPCR 
(Figure 3.4F,G; Figure 3.6B,C). These results indicate that Arid3a is required for the 
structural organization of various layers of the placenta.  
Aberrant expression of subtype-specific markers in Arid3a null placentas 
We further examined expression levels of key genes previously shown to be vital to 
placental development (Rossant and Cross, 2001). Upon KO of Arid3a (Figure 3.6A), 
genes required for trophoblast lineage development, SpT maintenance, labyrinthine 
development, and nutrient transport across the labyrinth pathway were highly down-
regulated (Figure 3.6B,C). Conversely, key markers of ectoplacental cone function and 
chorioallantonic fusion were unchanged (Figure 3.6C).  
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Figure 3.4. Arid3a KO in mouse embryos results in defects in placental structural organization. (A-H) 
Immunohistochemistry of Arid3a WT and KO sagittal placental cross sections stained with 
Hematoxyline and Eosin (H&E) and antibodies against: (A) ARID3A; (B) HAND1; (C) PROLIFERN; 
(D) PLACENTAL LACTOGEN (PL1); (E) ASCL2; (F) CDX2; (G) GCM1 (H). D, Decidua; TGC, 
Trophoblast giant cells; SpT, Spongiotrophoblasts 
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To confirm and extend the RT-qPCR results, we generated expression profiles of 
Arid3a KO and WT placentas by RNA-seq. We identified approximately 8,000 and 2,000 
differentially expressed genes at E10.5 and E11.5, respectively (cut-off threshold ≥1.5-
fold; Figure 3.6D,F). Differentially up-regulated genes at E10.5 were strongly enriched in 
gene ontology (GO) terms associated with immune system-related processes, including 
the response to external stimuli and defense response (Figure 3.6E). Conversely, genes 
down-regulated upon KO were enriched in general metabolic and structural processes, 
such as anatomical structure and pattern specification (Figure 3.6E).  
Activation of the inflammatory response in Arid3a null placentas 
Further inspection of our global expression profiles (Figure 3.6E,G) revealed that 
ARID3A is a critical regulator of innate immunity responses in the placenta. As shown in  
Figure 3.5. Arid3a KO in mouse embryos results in defects in placental structural organization. (A) 
Immunohistochemistry of E9.5 Arid3a WT and KO sagittal placental sections stained with 
Hematoxyline and Eosin (H&E) and antibodies against Arid3a, Proliferin, and Placental lactogen (Pl1). 
(B) Number of TGC counted per respective genotype at E10.5. 
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Figure 3.6. Arid3a KO results in aberrant expression of subtype-specific placental markers. (A) 
Expression levels of Arid3a in WT and KO placentas. (B,C) Expression levels of placental lineage 
markers as determined by RT-qPCR. All data are plotted relative to WT levels. Error bars indicate 
standard deviations of biological duplicates. (D, F) An unsupervised hierarchical clustering of transcript 
disruption by Arid3a KO using a cutoff threshold of 1.5-fold from expression profiles of Arid3 at E10.5 
and E11.5, respectively. (E, G) Significantly enriched GO terms (biological functions) of differentially 
expressed genes upon KO of Arid3a at E10.5 and E11.5; red, up-regulated and green, down-regulated 
genes. 
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Figures 3.7A-C, KO of Arid3a at E10.5 led to up-regulation of transcripts encoding 
inflammatory chemokines (eg, Ccl12, Ccl17, Ccl8, Ccl5), cytokines (eg, Il1a, Lta, Ltb, 
Mif), and several other inflammatory mediators (eg, Fcer1g, Nkx2-3, and Cd4), whereas 
at E11.5, transcripts encoding pro-apoptotic factors (eg, E2f3, Tnfrsf10b, and Bcl2l13) 
were up-regulated. These results are consistent with the data of Figure 3.3D and our 
recent analyses of Arid3a KO hematopoiesis (Kim et al., 2016), suggesting that E10.5 
Arid3a-deficient placentas are undergoing inflammatory-mediated swelling followed at 
E11.5 by apoptotic-mediated atrophy. 
  
Figure 3.7. Activation of innate immune response in Arid3a null placentas. (A) Alteration of expression 
associated with innate immunity in Arid3a KO placentas assessed by RT-qPCR. (B) Expression levels 
of apoptosis mediators altered in Arid3a KO placentas as assessed by RNA-seq. (C) 
Immunohistochemistry of Arid3a WT and KO placental sections stained with antibodies against E2f3. 
(D) Expression levels of inflammatory response-related genes, cytokines and chemokines upregulated 
in Arid3a KO placentas as assessed by RNA-seq. 
 
 71 
We also noted that several angiogenic factors and their receptors, including the 
soluble Fms-like tyrosine kinase (sFlt-1) and placental growth factor (Plgf) are 
significantly deregulated in Arid3a KO placentas at E10.5 but return close to normal 
levels at E11.5 (Figure 3.6F, 3.7D). Excessive inflammation and angiogenic imbalance 
often underlies symptoms associated with PE (Perez-Sepulveda et al., 2014); readdressed 
in Discussion). 
Loss or gain of Arid3a disrupt expression levels of key TS and TGC differentiation 
markers 
We first examined the effect of Arid3a loss on inflammatory chemokine expression 
following shRNA-based KD of Arid3a. We obtained > 70% KD efficiency at the mRNA 
level (Figure 3.8A). Arid3a-deficient TS cells revealed deregulation of several 
inflammatory chemokines (e.g., Ccl8, Ccl12, Ccl17) as well as upregulation of several 
inflammatory mediators (e.g., Nkx2-3, and Cd4) (Figure 3.8A). Next, we assessed 
expression levels of key markers of TE development. As shown in Figures 3.8B and C, 
well established markers (e.g., Cdx2, Hand1, Gata3, Eomes, and Tcfap2c) were down- or 
up-regulated upon Arid3a KD or OE, respectively.  
 Finally, to better understand the consequences of Arid3a loss on further 
differentiation to mature trophoblastic lineages, we performed in vitro differentiation of 
Arid3a-deficient TS cells as previously described (Tanaka et al., 1998)(Figure 3.8D). We 
observed marked deregulation of Hand1, which is essential for TGC differentiation (Scott 
et al., 2000), Cdx2, an early and essential marker of TE polarity and integrity of the TE 
epithelium (Strumpf et al., 2005), Gcm1, which promotes differentiation of underlying 
cytotrophoblast cells into the outer syncytiotrophoblast layer (Bainbridge et al., 2012) 
and Ascl2, which is required for the maintenance of TGC precursors (Guillemot et al., 
1994). Also significantly deregulated was the labyrinth marker, Pparγ, which promotes 
labyrinthine trophoblast differentiation via Gcm1-regulation (Fournier et al., 2008).  
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These results suggest that Arid3a gain or lost leads to significant changes in TS cell 
inflammation, development and differentiation, particularly within the TGC lineage, 
whose numbers and disorganization are apparent by IHC (Figure 3.4).  
Human ARID3A levels are induced by BMP4 and ARID3A OE leads to down-
regulation of pluripotency and up-regulation of TE-associated gene expression 
Our meta-analyses of the data of Li et al (2013) indicated that ARID3A is highly 
expressed in the developing human placenta and in TS-like cells (Figure 3.2A,C). As an 
initial approach to circumvent the ethical limitations of studying human 
placental function in vivo, we generated human “TS-like” cells (Xu et al., 2002) by 
Figure 3.8. Loss or gain of Arid3a disrupts expression levels of key TE markers in mouse TS cells. (A) 
Inflammatory chemokine markers are up-regulated following Arid3a KD in mouse TS cells as 
measured by RT-qPCR. Asterisks indicate significance (minimally) of p≤0.05 of at least 3 independent 
biological replicate; error bars indicate standard deviation of biological triplicates. (B,C) Expression 
levels of key markers of TE development are down- or up-regulated upon Arid3a KD (B) or OE (C) in 
TS cells, respectively. (D) In vitro differentiation of Arid3a-deficient TS cells perturbs gene expression 
corresponding to essential layers of the placenta as compared to differentiated WT TS cells. 
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addition of BMP4 to human iPS cells in feeder-conditioned medium (FCM) cultures. 
This treatment, while controversial (further addressed in Discussion), is generally 
acknowledged to induce TE differentiation.  
BMP4 induction led to both increased ARID3A levels as well as cytoplasmic to 
nuclear translocation of ARID3A (Figure 3.9A,B). Transient transfection of ARID3A into 
these TS-like cells increased its levels ~8-fold (without alteration of the differentiated 
morphology induced by BMP4/FCM) and up-regulated the TE-markers, GATA3 and 
GCM1 (Figure 3.9A,C). Conversely, shRNA-mediated ARID3A KD de-repressed 
transcription of pluripotency genes (OCT4 and NANOG) while repressing transcription of 
TE genes (Figure 3.9D). This may provide a mechanism by which ARID3A loss delays 
differentiation of human ES cells to TS-like cells.   
3.4 DISCUSSION 
Here we show that ARID3A plays a vital role in mouse placentation by contributing to 
the structural integrity of the placenta as well as by mediating communication among 
critical effectors, such as cells of the innate immune system. Our initial in vitro 
investigation in the human model further supports a requirement for ARID3A in initiation 
of ES to TS-like cell conversion through modulation of underlying transcriptional 
programs. Taken with our previous mechanistic observations (Rhee et al., 2014), our 
results identify ARID3A as an indispensable component of placental commitment, 
hemostasis and immune tolerance. 
Anchoring the conceptus to the uterus is a critical placental function. In mice, TGCs 
perform this role, and the bHLH TF, Hand1, is critical (Riley et al., 1998; Scott et al., 
2000). Hand1 expression was not altered by loss of Arid3a. Instead, the most striking 
consequence of Arid3a deficiency was displayed morphologically. While specific sub-
lineages can be delineated, they are highly disorganized with reduced cellularity (Figure 
3.4). That along with the expression data of Figure 3.6 supports an interpretation in which 
both layers and genes underlying their formation are deregulated in Arid 3a nulls. 
Addressing this observation in vitro by employing isolated cell cultures would contribute  
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significantly, but it would not fully resolve the in vivo defects. That will require loss of 
function analyses of specific sub-lineage-restricted master transcription factors. 
Additional important questions to be resolved by future studies are the mechanisms by 
which Arid3a maintains this structural integrity and the precise consequences of Arid3a 
loss on TGC transcriptional programs. 
Figure 3.9. ARID3A loss or gain disrupts expression levels of key TE markers in human TS-like cells. 
(A) BMP4-mediated human TS-like cells with ARID3A OE show differentiated morphology. ARID3A 
KD in TS-like induces a rounded morphology, indicative of a pluripotent state indistinguishable from 
human iPS cells. (B) Immunofluorescence images of control iPS and TS-like cells stained with directly 
conjugated anti-ARID3A (green; Alexa 594) and DAPI (blue). (C) Trophoblast lineage markers (red) 
and pluripotency factors (green) are up-regulated following ARID3A OE as measured by RT-qPCR. 
Error bars indicate standard deviation of biological duplicates. (D) Trophoblast lineage markers and 
pluripotency factors are down-regulated following KD of ARID3A. 
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Global RNA expression profiling confirmed that ARID3A function extends beyond 
the “first cell fate decision” (Rhee et al., 2014) to additional cellular processes vital to 
placental development, including placental structure, metabolism, immune tolerance and 
angiogenesis. Innate immune cells, typically placental NK, switch from a tolerogenic, 
anti-inflammatory phenotype to a cytotoxic, pro-inflammatory phenotype upon the 
sensing of pathogens or endogenous danger signals (Perez-Sepulveda et al., 2014). In our 
case, we suggest the trigger was loss of Arid3a. As cytotoxic effectors, innate immune 
cells create a state of inflammation, via cytokine and chemokine release, and placental 
ischemia, through reduced angiogenesis and increased vasoconstriction—the phenotype 
observed at E10.5 in Arid3a
-/-
 placentas. We recently published a detailed analysis (Kim 
et al., 2016) of the inflammatory consequences of ARID3A loss on embryonic 
hematopoiesis. In those studies, conducted at the same embryonic time points as analyzed 
here, we observed inflammatory consequences of a prototypical TH1 response—most 
notably, a significant increase in IFNα. However, the immune profiles of our null 
placentas displayed no significant overlap with the INFα target genes of Kim et al. (2016) 
nor with other targets deregulated in the null maternal embryo. This indicates that a large 
component of the observed placental inflammation is intrinsically derived. ARID3A is 
also required at later stages of embryogenesis for normal erythroid lineage differentiation 
and hematopoietic stem cell production (Kim et al., 2016; Webb et al., 2011).  
The in vivo authenticity of the previously characterized mesoderm inducer, BMP4, in 
human TS induction has been challenged (Bernardo et al., 2011; Ezashi et al., 2012; Li 
and Parast, 2014). However, more recently and well after the BMP4 debate arose, a 
number of groups have confirmed that the BMP4 system can induce TS-like cell 
phenotype. For example, Kurek et al (2015) showed conclusively that BMP-alone targets 
are required and sufficient for mesoderm induction, whereas trophoblast induction is 
WNT dependent, suggesting that exclusive differentiation toward either lineage is 
possible in BMP4 cultures. Yabe et al (2016) found that, when BMP4 is used in 
combination with ACTIVIN and FGF2 signaling inhibitors, trophoblast differentiation 
was significantly more efficient and synchronous. Taken in this context, we feel that our 
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approach—to determine the effect of ARID3A loss or gain in producing in vitro “TS-
like” cells from human ES/iPS cells—is rational.  
We observed that, as in the mouse (Rhee et al., 2014), Arid3a overexpression under 
BMP4-mediated culture conditions did convert human iPS to a more TS-like phenotype 
via downregulation of pluripotency genes and upregulation of trophoblast genes (Figure 
3.9C,D). However, not all our findings in mouse were conserved in the human. For 
example, in mouse blastocysts and placenta (Rhee et al., 2014), ARID3A activates 
CDX2, a transcription factor required for the initiation of TS commitment (Dietrich and 
Hiiragi, 2007). However, in the BMP4-induction hES cell system, ARID3A loss had no 
effect on CDX2 expression. This is consistent with observations that CDX2 expression is 
maximized in the non-trophoblast (mesoderm-derived) component of the human chorion 
(Bernardo et al., 2011; Niakan and Eggan, 2013). A further difference was that the 
reciprocal CDX2-OCT4 expression patterns established in the mouse are not conserved 
in the human (Hay et al., 2004). The human embryo shows a lag in trophoblast lineage 
segregation, with a period of time during which OCT4 and CDX2 are co-expressed in the 
TE (Niakan and Eggan, 2013). Nonetheless, we observed ARID3A-mediated repression 
of human OCT4, even though its human regulatory elements have diverged to a point 
such that they are not repressed when enforced into mouse TE (Molineris et al., 2011). 
While its specific role in human placentation remains to be elucidated, our findings 
establish that ARID3A is instrumental to trophoblast lineage determination.  
Preeclampsia (PE) is a major cause of pregnancy-associated morbidity and mortality, 
affecting 2-5% of pregnancies worldwide after 20 weeks of gestation (Ananth et al., 
2013). Normal placental function depends on trophoblastic invasion of the maternal 
decidua, myometrium, and blood vessels (Li and Parast, 2014). Fms-like tyrosine kinase 
1 (sFLT-1) and placental growth factor (PlGF) are key among angiogenic and anti-
angiogenic and mediators implicated in PE pathology (Levine et al., 2006). A recent 
study (Zeisler et al., 2016) demonstrated that the ratio of sFLT-1 to PlGF is elevated in 
the blood of pregnant women prior to the onset of PE. As shown in Figure 3.7, Arid3a 
activates both sFLT1 and PIGF, as well as the additional inflammatory agents, 
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ENDOGEN, and VEGFR-2. Additional Arid3a targets associated with PE include 
PPARγ and GCM1 (Chen et al., 2004; Waite et al., 2000). Our meta-analyses of placental 
PE data sets (Bilban et al., 2009; Founds et al., 2011) identified ARID3A and ELF5 as 
the only two deregulated transcription factors associated with human TE specification 
and/or differentiation. 
In summary, ARID3A is vital not only for maintaining proper intrauterine growth but 
also for maintaining a properly balanced immune system during pregnancy. Our data 
indicate that, as suggested by previous TS cell studies in vitro (Rhee et al., 2014), 
ARID3A is required for normal murine trophoblast development in vivo. However, it is 
important to note that while numerous pathways are deregulated, the etiology of the 
initiating placental defect in the mouse remains to be determined. It is unclear and the 
focus of future studies as to whether the primary defect is a direct consequence of the 
Arid3a null placenta, is secondary to a failing embryo/fetus or is derived from a 
combination of these events. Finally, we suggest that the use of ARID3A as a biomarker 
may provide a diagnostic, noninvasive predictive molecule to identify mothers at risk for 
defective deep placentation syndromes. 
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CHAPTER 4: MECHANISMS OF TRANSCRIPTION FACTOR-
MEDIATED DIRECT REPROGRAMMING OF MOUSE 
EMBRYONIC STEM CELLS TO TROPHOBLAST STEM-LIKE 
CELLS 
4.1 INTRODUCTION 
During normal embryonic development, differential gene expression across various 
tissues irreversibly determines cellular identity. However, advances in transcription factor 
(TF)-mediated direct reprogramming have revealed the plasticity of cell identity and the 
feasibility of cell fate conversion both in vitro and in vivo (Aoi et al., 2008; Davis et al., 
1987; Feng et al., 2008; Ieda et al., 2010; Kulessa et al., 1995; Nerlov and Graf, 1998; 
Takahashi and Yamanaka, 2006). To successfully convert cell fate, global gene 
expression in conjunction with the chromatin landscape must be altered in the original 
cells to a state favorable to a reprogrammed cell type. However, little is known about the 
mechanism of how and to what extent altered expression of TFs modulates chromatin 
architecture and global gene expression program changes. Although models for gene 
activation during reprogramming have been proposed, little is known about how 
repression of genes specific for the original cell type occurs.  
Induced pluripotent stem (iPS) cells can be generated from overexpression (OE) of a 
handful of TFs (e.g., Oct4, Sox2, Klf4, and Myc) in fibroblasts. Reprogramming to iPS 
cells can be broadly divided into two gene activation phases: a long stochastic phase 
followed by a shorter deterministic phase (Stadtfeld et al., 2008). Initially, cells undergo 
increased proliferation and alterations in histone modifications to initiate mesenchymal-
to-epithelial transition. Later, cells stochastically undergo an epigenetic reset, as well as 
activation of their target cell-specific transcriptional networks to stabilize the  
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reprogrammed cells. Another recently reported gene activation mechanism during 
reprogramming is the ability by which ectopically expressed TFs act as “pioneer” factors 
(Zaret and Carroll, 2011). Pioneer factors initially bind to closed chromatin of genes 
specific to the target cell type. Once bound, pioneer factors interact with chromatin 
modifying enzymes or remodeling complexes to convert closed into open chromatin, 
thereby activating initial cell-specific genes. For example, early in reprogramming, Oct4, 
Sox2, and Klf4 function as pioneer factors by accessing closed chromatin of distal 
regulatory elements of pluripotency genes, such as Esrrb and Sall4 (Soufi et al., 2015). 
Ascl1, a TF capable of converting fibroblasts to induced neuronal (iN) cells, also works 
as a pioneer factor (Wapinski et al., 2013). Although activation of repressed genes can 
indirectly suppress actively expressed genes, it remains unclear as to how active genes 
are directly repressed, and whether activation and repression of sets of genes occur 
simultaneously or sequentially in an ordered manner.  
Embryonic stem (ES) cells can undergo trans-differentiation or reprogramming to 
trophoblast stem (TS)-like cells whose properties are highly similar to genuine 
multipotent TS cells (Kuckenberg et al., 2010; Niwa et al., 2005; Ralston et al., 2010; 
Rhee et al., 2014). Several studies showed that the introduction of individual 
trophectoderm (TE)/TS cell-specific TFs (including Cdx2, Eomes, Tcfap2c, Gata3, and 
Arid3a) into ES cells drives their fate to TS-like cells. This transition is evidenced by 
alterations in cell morphology and in global gene expression in a manner similar to 
genuine TS cells (Kuckenberg et al., 2010; Niwa et al., 2005; Ralston et al., 2010; Rhee 
et al., 2014). In particular, TS-like cells generated by OE of Cdx2 and Arid3a were 
successfully incorporated into the TE of developing embryos and contributed to placental 
lineages ex vivo (Rhee et al., 2014). These findings raised the feasibility of generating 
functional TS-like cells from ES cells. ES to TS-like cellular conversion also has served 
as a valuable in vitro system for mechanistic understanding of the “first cell fate 
decision” (Zernicka-Goetz, 2004) as well as for TE lineage specification and 
differentiation. Thus, we reasoned that such an approach would allow us to thoroughly 
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interrogate mechanisms of transcriptional and epigenetic regulation by OE of single TFs 
during reprogramming.  
Here, we employed an ES to TS-like cell reprogramming system via OE of three key 
TE/TS cell-specific TFs – Cdx2, Arid3a, and Gata3 (herein referred to as CAG factors). 
Each of these TFs are well-known for being instrumental in trophoblast differentiation 
and placental development (Niwa et al., 2005; Ralston et al., 2010; Rhee et al., 2014). For 
instance, OE of Cdx2 and Arid3a in ES cells can generate functional TS-like cells ex 
vivo, and Gata3 is one of the factors used to generate induced TS (iTS) cells from 
fibroblasts. We investigated the dynamics of CAG factor binding as well as subsequent 
effects on chromatin accessibility and global gene expression during the initiation phases 
of reprogramming. We found that CAG factors orchestrate reprogramming of ES cells to 
TS-like cells via a two-step mechanism. First, each of these factors represses ES cell-
specific genes through decommissioning of their associated active enhancers in ES cells. 
Second, individual CAG factors activate TS cell-specific genes by switching their own 
DNA-binding motifs from one that binds to ES cell-specific regulatory regions to 
elements specific to TS cells. Ultimately, each CAG factor gradually changes its 
chromosomal targets throughout the reprogramming process to achieve sequential 
repression followed by activation.  
4.2 MATERIALS AND METHODS 
Cell culture  
Mouse J1 ES cells were cultured in DMEM (Dulbecco’s modified Eagle’s medium) 
supplemented with 18% fetal bovine serum (FBS), 2mM L-glutamine, 100 µM of non-
essential amino acid supplement, nucleoside mix (100X stock, Sigma), 100 µM of β-
mercaptoethanol, 1000U/ml of recombinant leukemia inhibitory factor (LIF, Chemicon), 
and 50U/ml of penicillin/streptomycin. ES cells were plated on 0.1% gelatin coated 
dishes. Mouse TS cells were maintained at a ratio of 3:7 of TS medium to MEF-
conditioned TS medium, supplemented with 25ng/ml Fgf4, and 1µg/ml heparin. TS 
medium is RPMI 1640 (Roswell Park Memorial Institute medium, Gibco) supplemented 
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with 20% FBS, 100µM β-mercaptoethanol, 2mM L-glutamine, 1mM sodium pyruvate, 
penicillin (50U/ml), and streptomycin (50mg/ml). MEF-conditioned medium is TS 
medium conditioned by MEF. MEF were treated with mitomycin, followed by culturing 
for 3 days. The medium was collected every 3 days for three times. 293T cells were 
maintained in DMEM supplemented with 10% FBS, 2mM L-glutamine, and 50U/ml of 
penicillin/streptomycin. All cells were incubated at 37°C, 5% CO2. 
Generation of stable cell lines 
Individual coding sequences of CAG factors were amplified by PCR using mouse cDNA 
clones (Origene, MC208274 for Cdx2, MC205205 for Arid3a, and mouse TS cell cDNA 
for Gata3) as a template, and then cloned into the pEF1α-FLBIO vector (Wang et al., 
2006). The vector was transfected into BirA expressing ES cells by electroporation. The 
positive biotin-tagged OE stable cells were picked and maintained in ES media 
supplemented with puromycin (Invitrogen) and geneticin (Gibco). Ectopic expression 
levels were measured by RT-qPCR and Western blotting. Primer sequences for PCR are 
listed in Appendix. 
Generation of inducible cell lines 
Coding sequence of Arid3a amplified by PCR using mouse cDNA clones (Origene, 
MC205205) as a template, and then cloned into the pLVX-TRE3G-ZsGreen1 vector 
(Clontech, 631361). Clones were sequence-verified prior to use. Lentiviral production 
and infection were performed as described below. ES cells were plated at ~1 x 10
6
 cells 
per 6-well plate with virus-containing supernatant (co-infection of pLVX-TRE3G-
ZsGreen1 and pLVX-EF1α-Tet3G vectors). The cells were placed under neomycin and 
geneticin selection for 2 days followed by replacement of medium with fresh ES cell 
medium plus 1µg/mL doxycycline. ES cell medium containing doxycycline was changed 
each day for ~6 days. Ectopic expression levels were measured by RT-qPCR. Primer 
sequences for PCR are listed in Appendix. 
Lentiviral production and infection 
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Lentiviral production was performed in 293T cells. 293T cells were plated at ~6 X 10
6
 
cells per 100mm dish and incubated overnight. Cells were transfected with 6µg of pLVX-
TRE3G-ZsGreen1 or pLVX-EF1α-Tet3G vectors (for the inducible cell line, Clontech, 
631359) with 4µg of pCMV-Δ8.9 and 2µg of VSVG helper plasmid using Fugene 
(Promega), according to the manufacturer’s instructions. After 15 hours, 293T medium 
was replaced with ES medium. The supernatants containing viral particles were harvested 
48 hours after transfection, filtered through 0.45µm pore-size cellulose acetate filters, and 
supplemented with polybrene (Millipore). Infections were performed with cells plated at 
a density of ~1 x 10
6
 cells per 6-well plate with virus-containing supernatant 
supplemented with polybrene (Millipore). 
Quantitative gene expression analysis 
For RT-qPCR, total RNA was first isolated using the RNeasy Mini Kit (Qiagen). 500ng 
total RNA was then used to synthesize cDNA with qScript cDNA supermix (Quanta). 
RT-qPCRs were performed using PerfeCTa SYBR Green FastMix (Quanta) with 2uL of 
20X diluted cDNA generated from total RNA. Using Primer 3 (Koressaar and Remm, 
2007), RT-qPCR primers were designed to amplify an ~100bp region containing the 
junction between the two exons. For ChIP-qPCR, the primers were designed to amplify 
~100bp regions centered on the putative binding sites. The Ct values obtained from qPCR 
were normalized against Gapdh for gene expression and against Gfi1b_proximal sites to 
determine relative gene expression and ChIP enrichment, respectively. Primer sequences 
for qPCR are listed in Appendix. 
Western blotting 
Proteins were lysed from cultured cells using RIPA Lysis and Extraction Buffer (G-
Biosciences) with protease inhibitor cocktail (Roche), followed by incubation at 100°C 
for 20 minutes. Cell lysates were separated by electrophoresis on 4-20% gradient 
acrylamide gels and transferred to PVDF membranes. The blots were blocked with TBS-
T (20mM Tris-HCl, pH 7.6, 136mM NaCl, and 0.1% Tween-20) containing 5% BSA 
(bovine serum albumin) for 1 hour and then incubated with primary antibody solution at 
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4°C overnight. After washing with TBS-T, the membranes were incubated with HRP-
conjugated secondary antibodies for 1 hour at room temperature (RT). Then the 
membrane was washed with TBS-T, followed by developing with ECL reagents (GE 
Healthcare). Antibodies used for Western blotting were anti-Cdx2 (1:1000, ab88129, 
Abcam), anti-Arid3a (1:5000;(Webb et al., 2011)), anti-Gata3 (1:1000, SC-9009, Santa 
Cruz), anti-β-actin (1:10000, ab20272, Abcam), and anti-Hdac1 (1:1000, ab7028, 
Abcam).  
Co-immunoprecipitation 
One-step affinity purification with streptavidin-agarose beads (Invitrogen) using ~2 x 10
7
 
cells from ES cell lines expressing BirA only or BirA plus biotin-tagged proteins was 
performed as previously described (Kim et al., 2010). The final pulled-down proteins 
were eluted in Laemmli buffer prior to Western blotting. 
RNA-sequencing analysis 
Libraries were prepared with an RNA library preparation kit (E7490, NEB) using 1µg of 
RNA obtained by the RNeasy Mini Kit (Qiagen). RNA-seq libraries were sequenced with 
a 1 x 75-bp strand-specific protocol on a NextSeq 500 (Illumina). Data were analyzed 
using a high-throughput next-generation sequencing analysis pipeline: FASTQ files were 
aligned to the mouse genome (mm9, NCBI Build 37) using TopHat2 (Kim et al., 2013). 
Gene expression for the individual samples was calculated with Cufflinks (Trapnell et al., 
2010) as RPKM values. RNA-Sequencing data are submitted to the NCBI Gene 
Expression Omnibus (GEO) under accession number GSE90752. 
ChIP-sequencing 
ChIP assays were performed with ES cell lines expressing BirA only (reference) or both 
BirA and biotin-tagged proteins (samples) as previously described (Kim et al., 2008) 
using streptavidin magnetic particles (Roche). Additional ChIP assays were carried out in 
ES, OEArid3a_ES+, OEArid3a_TS+, and TS cells using Arid3a (Webb et al., 2011), 
Hdac1 (ab7028, Abcam), and H3K27ac (ab4729-100, Abcam) antibodies. ChIP-
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sequencing libraries were generated using ChIP-seq library prep kits (NEB) according to 
the manufacturer’s instructions. ChIP-sequencing libraries were sequenced using 
Illumina NextSeq 500 at the Genomic Sequencing and Analysis Facility (GSAF), The 
University of Texas at Austin. ChIP-Sequencing data are submitted to the NCBI Gene 
Expression Omnibus (GEO) under accession number GSE90752. 
ATAC-sequencing 
ATAC assays were performed as previously described (Buenrostro et al., 2015). We used 
~ 50,000 cells to start the experiment. The cells were incubated with transposition 
reaction mix for 30 min followed by PCR reaction for 18 cycles. ATAC samples in the 
~250bp range were isolated using E-gel size select chromatography. ATAC-sequencing 
was performed using Illumina NextSeq 500. ATAC-Sequencing data are submitted to the 
NCBI Gene Expression Omnibus (GEO) under accession number GSE90752. 
Identification of ChIP- and ATAC-sequencing peaks 
FASTQ files were aligned to the mouse genome (mm9, NCBI Build 37) using Bowtie 
2.2.5. For the identification of peaks, model-based analysis with the ChIP-seq (MACS 
2.1.1) peak caller (Zhang et al., 2008) was used with a default setting (macs2 callpeak –t 
Sample.sam –c Control.sam –f SAM –g mm –n) with keeping 5 duplicates. The ChIP-seq 
signals resulting from BirA-only expressing ES cells and Mock samples were subtracted 
to remove background noise for ChIP by incubation with streptavidin magnetic particles 
and native antibodies, respectively. ATAC-seq signals were normalized to the default 
background. We readily identified several thousand, significant individual CAG occupied 
loci upon filtering high-quality peaks based on p-values. Genes occupied by TFs within a 
10Kb window (8Kb upstream to 2Kb downstream of TSS) were considered target genes 
and used for subsequent analyses. In order to summarize the peak signal enrichment over 
control experiments, z-score bedGraph files were produced, and following background 
subtraction, the bedGraph files were constructed using MACS2 version 2.1.1 with 
‘bdgcmp –m logLR’ command. Peaks were visualized using the Integrative Genome 
Viewer from the Broad Institute.  
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Motif analysis 
Both de novo and known motifs in peak regions in the genome were identified using 
Homer (Heinz S et al., 2010) with the fragment size for motif finding set as 100bp. 
Heat maps 
All heat maps were generated using JavaTreeview (Saldanha, 2004). 
Gene Ontology (GO) analysis 
DAVID 6.7 (Huang et al., 2009) was used for analysis of differentially expressed genes 
obtained from the expression profile data. TF targets and Genomic Regions Enrichment 
of Annotation Tool (GREAT) (McLean et al., 2010) was used for ChIP-seq peak 
analysis. 
Correlation maps 
Common binding sites of the indicated TFs were identified by peak calling with an 
overlap analysis. The binding sites of two TFs were calculated for with a paired-end 
Pearson correlation coefficient. 
Principle component analysis (PCA) 
The R prcomp was used to perform PCA on the RNA-seq data.  
Dendrogram 
R hcluster was used to generate dendrograms of RNA- and ATAC-seq data. 
Public data sets used 
ChIP-sequencing data sets used for the analyses were obtained from the Gene Expression 
Omnibus (GEO) database under the accession numbers GSE31039 (H3K27ac, ES cells), 
GSE42207 (H3K27ac, TS cells), and GSE11724 (Oct4, ES cells). 
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4.3 RESULTS 
Ectopic expression of individual CAG factors in ES cells promotes changes in global 
gene expression and chromatin landscape toward TS cells 
OE of either of the aforementioned TE/TS cell-specific CAG factors (Cdx2, Arid3a, and 
Gata3) previously was shown to convert mouse ES cells to TS-like cells (Niwa et al., 
2005; Ralston et al., 2010; Rhee et al., 2014) To determine how these CAG factors 
initiate reprogramming, we designed our experimental set-up as shown in Figure 4.1A. 
Individual CAG factors were expressed under the control of constitutively active pEF1α 
promoters. After establishing clones, the cells were maintained for 4 days in ES cell 
culture media (ES+). The ES media was then replaced with TS media (TS+) to optimize 
conditions for reprogramming (detailed procedures in Materials and Methods). During 
the ES to TS-like cell fate conversion, we monitored changes in cellular morphology, 
global gene expression, chromatin accessibility, and CAG factor occupancy at days 4 
(ES+) and 8 (TS+).  
   
Figure 4.1. OE of single CAG factors in ES cells converts ES cells to TS-like cells. (A) Schematic 
diagram of the experimental design employed to generate TS-like cells from ES cells. (B) Western 
blotting showing protein levels of the CAG factors in ES cells and TS cells at different stages (ES+ and 
TS+) of the reprogramming upon OE of CAG factors. β-Actin was used as a loading control. (C) Bright 
field images depicting changes in cell morphologies associated with conversion of ES to TS-like cells at 
different stages of reprogramming. 
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We first confirmed OE of CAG factors in ES cells by Western blotting (Figure 
4.1B,C). Consistent with previous reports (Niwa et al., 2005; Ralston et al., 2010; Rhee et 
al., 2014), OE of individual CAG factors in ES cells promoted dramatic morphological 
changes. Cells transitioned from spheroid colony morphology, typical of undifferentiated 
ES cells, to a flattened, epithelial-like morphology, indicative of an early stage of cellular 
conversion; this occurred even before replacing ES+ media with TS+ media (Figure 
4.1C; upper panels). Under TS+ media conditions, cells adopted an even more prominent 
TS-like morphology (Figure 4.1C; lower panels). Parallel to these morphological 
changes, TE/TS cell-specific marker genes also were upregulated over time (Figure 
4.2A), indicating that our experimental system was valid for investigating the early stages 
underlying CAG-mediated conversion of ES to TS-like cells.  
Next we determined to what degree CAG factors affect global gene expression and 
chromatin configuration during ES to TS-like reprogramming, we profiled global gene 
expression by RNA-seq and chromatin accessibility by ATAC-seq at this early stage of 
reprogramming and then compared the results to transcriptional and chromatin analysis in 
ES and TS cells as controls. Indeed, at this early stage of reprogramming, global mRNA 
expression (and to a lesser extent, chromatin accessibility) had begun to transition in the 
OE cell lines from an ES cell state to a TS-like state. As shown in Figure 4.2B, we 
observed reduced levels of key ES cell-specific markers (including Oct4, Sall4, and 
Stat3) and induced levels of TE/TS cell-specific markers (including Eomes, Krt8, and 
Tead4) in CAG factor OE cells as compared to untreated ES cells. Principal component 
analysis (PCA) of these expression profiles showed a significant shift in the global 
expression pattern of ES cells toward TS cells (Figure 4.2C). Notable among the CAG 
factors, Arid3a induced an expression pattern most similar to that of bona fide TS cells 
(Figure 4.2D). Consistent with our RNA-seq results, OE of individual CAG factors 
induced alterations in ES cell chromatin accessibility more similar to that of TS cells 
(Figure 4.3A,B). Global changes in chromatin accessibility were minor compared to  
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to changes in expression levels. Still, a small portion of these changes are involved to be 
crucial markers of successful ES cell to TS-like cell conversion. Gene ontology (GO) 
term analysis revealed that regions that became more accessible (open) were enriched in 
genes involved in TE and placental development, while regions that became more 
inaccessible (closed) during reprogramming were implicated in embryonic stem cell 
maintenance (data not shown). Collectively, these results indicated that individual 
expression of CAG factors initiates  
Figure 4.2. Ectopic expression of individual CAG factors in ES cells promotes transition of global 
expression toward TS cells. (A) Expression analysis of TS cell-specific genes by RT-qPCR in stable 
individual CAG-OE ES cells. (B) A heatmap showing relative gene expression levels of ES- and TS 
cell-specific genes in reprogrammed cells relative to ES cells upon OE of CAG factors. ES cell- and TS 
cell-specific genes are labeled in red and green to the right side of the heatmap, respectively. (C) 
Principal component analysis (PCA) of time-course RNA-seq data showing gradual transition of the 
transcriptome from ES cells toward TS-like cells. (D) A dendrogram showing a similarity of expression 
profile among ES, TS, and CAG-mediated reprogrammed cells.  
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ES to TS-like cellular conversion by not only modulating global gene expression, but also 
by reshaping the chromatin landscape.  
CAG factors directly regulate both ES and TS cell-specific genes during ES to TS-
like cell reprogramming 
To examine how OE of CAG factors mediate global transcriptional changes during the 
reprogramming, we determined which classes of genes were directly regulated by CAG 
factor binding via genome-wide ChIP-seq. We found several thousand statistically 
significant individual CAG factor binding sites (detailed in Materials and Methods). 
Previous studies had shown that cellular identity is largely determined by distal 
regulatory elements, especially enhancers that are targets of cell type-specific TFs, during 
both development and reprogramming (Heinz et al., 2015). Consistent with this, we 
found that >60% of CAG target sites are within regions distal to their respective 
transcriptional start sites (TSSs), primarily distributed within intergenic (~40%) and 
upstream (~20%) regions during the initial stage (day 4, passage 2) of reprogramming 
(Figure 4.5A).  
Figure 4.3. Ectopic expression of each CAG factors in ES cells leads to changes in chromatin 
landscapes toward TS cells. (A) Dendrograms showing a similarity of chromatin landscapes among ES, 
TS, and CAG-mediated reprogrammed cells. (B) A heatmap depicting similarity of chromatin openness 
among ES, TS, and different stages of reprogrammed cells.  
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We next performed GO analysis of the genes associated with chromosomal targets of 
each CAG factor. As shown in Figure 4.4A, CAG factor targets were largely associated 
with both ES cell-specific terms (e.g., stem cell maintenance and blastocyst development) 
and TS cell-specific terms (e.g., embryonic placenta development and trophectodermal 
cell differentiation). Thus, individual CAG factors act as distal enhancer binding proteins 
during reprogramming to directly regulate both ES and TS cell-specific genes. 
Comparison of our ChIP-seq and RNA-seq data revealed that both activated and 
repressed genes upon OE of each TFs were largely direct targets of CAG factors during  
  
Figure 4.4. CAG factors possess dual functions during the reprogramming (earlier stage). (A) Bar 
graphs showing enriched GO terms of individual CAG factor targets. ES- and TS cell-specific functions 
are highlighted in red. (B) Venn diagrams depicting overlaps among genes bound by each CAG factor 
and genes that are either up- or down-regulated in ES cells upon OE of individual CAG factors. p-
values were calculated using hypergeometric tests. (C-D) Heatmaps ranking relative gene expression of 
CAG OE cells relative to ES cells (C) and TS cells relative to ES cells (D). Averaged occupancy scores 
calculated by moving average (window size, 250; bin size, 1) for individual CAG factors are plotted in 
black lines.  
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the early phase of reprogramming (Figure 4.4B, 4.5B). These results indicated that each 
CAG factor displays dual functions during reprogramming.  
To further characterize the relationship between CAG factor binding and 
differentially regulated genes, we analyzed the ChIP-seq data as a moving window 
average (window size, 250; bin size, 1; Figure 4.4C, 4.5C). We found that stronger peaks, 
which indicate stronger occupancy of the factor bound to DNA, are generally correlated 
with greater changes in gene expression (Figure 4.4C, 4.5C). Then, to determine which 
classes of genes are directly regulated by CAG factors, we compared the occupancy of target 
genes upon OE of individual CAG factors in ES cells to their relative expression TS (Figure 
4.4D, 4.5D). We found that the genes that are highly expressed in ES cells, well-
established ES cell-specific genes, are, in fact, direct targets of CAG factor binding, 
whereas TS cell-specific TFs are less strongly  
Figure 4.5. CAG factors possess dual functions during the reprogramming (later stage). (A) Bar graphs 
showing distribution of the binding sites of each CAG factors across the genome. (B-D) The same 
analyses shown in Figure 4.4B,C,D in order in TS+ media instead of ES+ media.  
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Figure 4.6. CAG factors directly activate and repress TS- and ES cell-specific genes, respectively. (A) 
Signal track images depicting occupancy of each CAG factor at both ES- and TS cell-specific genes 
upon OE in ES cells. (B) Bar graphs showing average expression levels of the top 150 ES cell-specific 
genes and the top 150 TS cell-specific genes upon OE of each CAG factor in ES cells. (C) Boxplots 
showing the distribution of expression levels of ES- and TS cell-specific genes upon OE of individual 
CAG factors in ES cells. The red dotted lines indicate median expression of ES- or TS cell-specific 
genes in ES cells. (D,E) The same analyses shown in Figure 4.6B,C in order in TS+ media instead of 
ES+ media. 
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Figure 4.7. Enrichment of CAG binding motifs depends on chromatin landscape. (A-C) Bar graphs 
showing the number of Cdx2 (A), Arid3a (B), and Gata3 (C) target genes whose regulatory regions are 
associated with open or closed chromatin at the different stages of the reprogramming. (D-F) Upon OE 
of individual CAG factors in ES cells, significantly enriched motifs of Cdx2 (A), Arid3a (B), and Gata3 
(C) binding sites that reside within open or closed chromatin are shown. Bar graphs (right panel) 
provide the percentages of individual CAG binding site with the motifs. 
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occupied by CAG factors (Figure 4.6A). Overall, our analysis revealed significant 
repression of ES cell-specific genes along with a slight induction of TS cell-specific 
genes at the early stage of programming; furthermore, the repression is mediated by 
direct binding of CAG factors (Figure 4.6B-E).  
Each CAG factor binds both open and closed chromatin during the early stage of 
reprogramming regardless of the presence of canonical motifs 
Given the importance of chromatin in global gene regulation and the fact that moderate 
changes in the chromatin landscape occurred shortly after CAG factor OE, we sought to 
determine whether CAG factors bind to open or closed chromatin. Previous studies 
introduced the “pioneer factor” concept as factors capable of binding directly to 
heterochromatin to activate silenced target cell-specific genes during reprogramming 
(Iwafuchi-Doi et al., 2016; Soufi et al., 2015). In order to investigate whether CAG 
factors function as pioneer factors and to what degree CAG factors bind to open and 
closed chromatin, we examined chromatin openness of individual binding sites during the 
reprogramming process. We observed that individual CAG factors prefer to bind open 
rather than closed regions of chromatin (Figure 4.7A-C); i.e., ~70% of Cdx2 and Gata3 
binding events occurred within open regions (Figure 4.7A,C). This suggested that CAG 
factors are distinct from pioneer factors. Unexpectedly, however, all CAG factors show 
fewer peaks at the later stage of reprogramming (TS+) compared to the earlier stage 
(ES+), indicating that CAG factors might be crucial during the initiation of 
reprogramming but play a more limited role thereafter (Figure 4.7A-C). Next we 
examined the positions of CAG factor open vs. closed chromatin genomic binding sites 
relative to TSSs. We found that regardless of chromatin status, CAG factors 
preferentially bound to distal regulatory elements (Figure 4.8A,B).  
Taken together, these results suggested that each CAG factor not only functions 
similar to pioneer factors by binding to closed chromatin for the activation of the desired 
(TS) cell type-specific genes, but also acts as a transcriptional repressor by binding to  
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Figure 4.8. CAG factors share a significant number of target sites regardless of chromatin accessibility. 
(A,B) Pie charts presenting the distribution of each CAG factor binding sites that are open (A) or closed 
(B) in ES cells across the genome upon OE of individual CAG factor in ES cells. (C) Venn diagrams 
showing overlaps of open (left) or closed (right) loci among each CAG factor OE cells. (D) Pie charts 
showing the distribution of open (left) or closed (right) loci across the genome that are overlapped with 
the binding sites of CAG factors in ES cells. (E) Gene ontology (GO) analysis showing enriched 
biological process terms of common targets of CAG factors whose regulatory elements are either open 
(left) or closed (right). (F) De novo motif showing enriched motifs in common peaks of CAG factors. 
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open chromatin to suppress active ES cell-specific genes. To further explore this 
hypothesis, we examined whether each CAG factor bound its own unique targets or 
whether they all shared common binding sites. Comparison of individual CAG factor 
binding sites revealed that CAG factors share a significant number of target sites 
regardless of chromatin accessibility (Figure 4.8C). CAG common peaks within open 
chromatin are predominantly located at distal elements as expected (91%), whereas 
closed chromatin peaks are exclusively located within distal elements (100%) - a strong 
indication of pioneer factor-like activity (Figure 4.8D). Common open chromatin loci 
occupied by all CAG factors are primarily ES cell-specific, as evidenced by GO term 
enrichment (e.g., stem cell maintenance and cell fate specification) and DNA-binding 
similarity with ES cell-specific TFs (Figure 4.8E,F). This suggested that CAG factors 
promote reprogramming by occupying open regulatory regions of the ES cell-specific 
genes prior to repressing them, and that each individual factor shares a similar 
mechanism of repression in terms of target genes. On the other hand, GO analysis 
revealed that common closed chromatin-associated targets are associated with the 
regulation of chromosome organization and other chromatin regulatory-related terms 
(Figure 4.8E). Thus, CAG factors appear to regulate the chromatin landscape by 
activating expression of genes implicated in chromatin remodeling or modification.  
To further address this interpretation, we performed motif analyses of individual 
CAG binding sites associated with the above observed open and closed chromatin 
regions. As shown in Figures 4.7D-F, top-ranked motifs associated with open CAG 
binding sites are ES cell-specific motifs (such as Oct4 and Sox2), whereas closed CAG 
target sites are enriched in TS cell-specific motifs (including Cdx2, Gata3 and Tead4). 
Unexpectedly, individual CAG binding sites were not enriched with chromosome 
organization-related motifs, indicating unlike their common targets, their unique targets 
might have high portion associated with TS cell-specific genes. Of particular note, CAG 
factors showed stronger occupancy signals at open rather than closed chromatin regions, 
even though these closed sites do not contain canonical CAG binding motifs (data not 
shown). These results suggest that CAG factors might aid binding of additional TFs by 
 97 
occupying target sites indirectly via protein-protein interaction or competition with core 
pluripotency factors.  
Arid3a promotes cell fate conversion by repression of ES cell-specific genes followed 
by activation of TS cell-specific genes 
Among the CAG factors, Arid3a OE produced TS-like cells most similar to bona fide TS 
cells at the transcriptional and epigenetic level compared to OE of Cdx2 or Gata3 (Figure 
4.2, 4.3). Therefore, we investigated Arid3a OE-mediated reprogramming in greater 
depth. We performed a de novo motif search for Arid3a binding sites over the course of 
reprogramming using the HOMER motif search tool (Heinz et al., 2010). Consistent with 
our previous study (Rhee et al., 2014), the motif constituting the predominant binding 
sites for Arid3a in ES cells is highly similar to the motif employed by Oct4 (Figure 
4.9A). Unanticipatedly, binding motif preferences of Arid3a gradually changed over time 
during reprogramming (Figure 4.9A). This prompted another HOMER motif search 
(Heinz et al., 2010) for previously established TF motifs spanning the binding sites of 
Arid3a. The analysis revealed that motifs for ES cell-specific pluripotency factors are 
enriched during the earlier time point of reprogramming (OEArid3a_ES+)(Figure 4.9B). 
Conversely, TS cell-specific motifs were overrepresented at the later reprogramming time 
point (OEArid3a_TS+)(Figure 4.9B). These data clearly demonstrate that Arid3a 
dynamically switches its target site specificity during the course of reprogramming, 
perhaps by undergoing conformational changes, switching its protein interaction partners, 
or by recognizing degenerate motifs. 
To further investigate this gradual shift in target site specificity and to elucidate its 
effect on repression, we assessed Arid3a occupancy over the course of reprogramming as 
well as the presence of H3K27ac - a histone mark enriched among active enhancers 
(Creyghton et al., 2010). We distinguished Arid3a target sites at different stages of 
reprogramming by clustering analysis. As shown in Figure 4.10A, we observed seven 
distinct patterns of Arid3a occupancy during the course of cell fate conversion. Class I 
and IV targets are mainly associated with stem cell development (Figure 4.10B). Strong  
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Arid3a occupancy signals were predominantly observed in the regulatory regions of 
genes in these two classes at the early reprogramming time point (ES+). This was 
consistent with our observations that CAG factors initially mediate repression (Figure 
4.10A). However, at the later time point (TS+), Arid3a occupancy of class I genes 
gradually disappears as occupancy shifts to class II and III genes (Figure 4.10A). In 
contrast to classes I and IV, genes belonging to class II and III are generally associated 
with TS cell-specific functions, such as placenta and labyrinthine development (Figure 
4.10B). These data reveal dynamic changes in global Arid3a occupancy; i.e., Arid3a  
Figure 4.9. Arid3a dynamically switches its target sites specificity during the course of reprogramming. 
(A) De novo motif analysis of Arid3a binding sites showing the transitions of Arid3a motifs during the 
conversion of ES to TS-like cells. (B) Bar graphs of enriched motifs within Arid3a binding sites in ES, 
TS, and two different stages of reprogrammed ES cells.  
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Figure 4.10. Arid3a promotes the reprogramming by repression of ES cell-specific genes followed by 
activation of TS cell-specific cells. (A,C,D) Heatmaps showing multiple clustered Arid3a binding sites 
(A), H3K27ac signatures (C), and chromatin landscapes that are dynamically changed depending on 
Arid3a occupancy during the reprogramming. (B) Significantly enriched terms of biological processes 
in the distal Arid3a binding sites of different classes by GO analysis. (E) Chromatin landscape changes 
in concert with changes in Arid3a occupancy plotted as a line graph showing average ATAC-seq peak 
scores within regions of Arid3a binding site classes shown in Figure 4.10A. 
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initially occupies ES cell-specific genes, presumably to repress them, followed by 
occupying TS cell-specific genes for their activation. 
Since the H3K27ac signature is associated with active enhancers, we inspected its 
enrichment near Arid3a binding sites associated with open chromatin. We observed a 
strong positive correlation between the H3K27ac signature and Arid3a occupancy at each 
stage of reprogramming (Figure 4.10A,C). Class I-associated genes are ES cell-specific, 
and thus, are associated with H3K27ac marks. However, as reprogramming proceeded, 
these H3K27ac marks gradually disappeared from class I peaks (Figure 4.10C). Thus, we 
suggest that the initial binding of Arid3a to class I peaks ultimately removes H3K27ac 
signals to promote the suppression of ES cell-specific genes. Conversely, genes 
associated in class III gradually gain H3K27ac marks along with Arid3a occupancy 
during the course of reprogramming, indicating that Arid3a binding positively regulates 
these TS cell-specific genes (Figure 4.10C). Taken together, our results indicate that 
Arid3a represses ES cell-specific genes by reducing levels of H3K27ac, while it activates 
TS cell-specific genes by increasing H3K27ac. Since Arid3a itself does not possess 
acetyltransferase or deacetylase activity, our results imply that Arid3a may recruit 
proteins with these enzymatic activities. The feasibility of such a mechanism was 
provided by our demonstration (Rhee et al., 2014) that Arid3a recruits Hdac1 and Hdac2 
to catalyze target repression. 
Consistent with changes in Arid3a occupancy during reprogramming, we found that 
chromatin accessibility is also altered (Figure 4.10D,E). Average ATAC-seq peak scores 
revealed that genes in classes I (ES cell-specific) and IV showed decreased accessibility 
along with loss of Arid3a occupancy during reprogramming, implying a gradual 
conversion to heterochromatin. Alternatively, class III (TS cell-specific) genes gained 
chromatin accessibility as Arid3a occupancy increased, consistent with conversion to 
euchromatin—consistent with classical pioneer factor activity (Figure 4.10E). Thus, 
during the course of reprogramming, Arid3a switches its distal regulatory targets from ES 
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cell-specific to TS cell-specific genes, resulting in a global shift in the transcriptional and 
epigenetic landscape from an ES to a more TS-like profile. 
CAG factors deactivates pre-existing ES cell-specific enhancers  
Based on our finding that individual CAG factors preferentially bind to loci distal from 
the TSSs of their target genes and that ES cell-specific genes are directly repressed by 
CAG factors, we reasoned that CAG factors might regulate the activity of ES cell-
specific enhancers. To investigate this possibility, we analyzed the overlap of CAG factor 
targets with ES cell-specific enhancers, as defined by the histone enhancer mark, 
H3K27ac, as well as by ES cell-specific “super-enhancers”—a cluster of enhancers 
densely occupied by the ES cell-specific pluripotency factors, P300, and Mediator 
(Whyte et al., 2013). We observed that >70% of CAG factor targets overlap with active 
enhancers defined by H3K27ac signals and that ~50% of ES cell-specific super-
enhancers are also occupied by CAG factors upon their OE in ES cells (Figure 4.11A,B). 
This indicated that CAG factors prefer to occupy active ES cell-specific enhancers when 
expressed in ES cells. In addition, binding sites for the ES cell-specific TF Oct4, 
previously defined in ES cells, also displayed significant overlap with CAG binding sites 
(Figure 4.11C,D).  
Based on these observations, we addressed two potential mechanisms of CAG-
mediated repression of ES cell-specific genes. First, CAG factors might compete with ES 
cell-specific TFs, such as Oct4, to bind to ES cell-specific enhancers. To test this 
hypothesis, we determined Oct4 occupancy upon OE of CAG factors in ES cells. Indeed, 
Oct4 occupancy was dramatically decreased, suggesting that there may be some level of 
binding competition among Oct4 and CAG factors at ES cell-specific enhancers (Figure 
4.11E). However, we also observed decreased levels of Oct4 expression during the 
course of reprogramming (data not shown); thus, we cannot rule out the possibility that 
this decreased Oct4 occupancy is a result of reduced levels of Oct4.  
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The alternative interpretation is that CAG factors deactivate ES cell-specific 
enhancers by modifying histone signatures. To test this possibility, we overexpressed 
Arid3a in ES cells using a doxycycline (dox) - inducible system. Cells were treated with 
dox for 4 days, followed by withdrawal and further culturing for 4 additional days. Dox-
dependent induction of Arid3a was confirmed by the expression of Zsgreen1 (Figure 
4.12A). Next, we determined by quantitative PCR whether enhancer-associated H3K27ac  
  
Figure 4.11. CAG factors decommission ES cell-specific enhancers. (A-C) Bar graphs depicting 
overlaps of individual CAG factor binding sites and target hub upon OE of each factor in ES cells with 
H3K27ac enriched sites (A), super-enhancers (B) and Oct4 binding sites (C) in ES cells. Myc binding 
sites in ES cells are used as negative control. Asterisks mark significant overlaps (P-value < 0.0001). 
(D) Average occupancy profiles of each CAG factor centered on Oct4 binding sites in ES cells 
following OE of CAG factors in ES cells. (E) Oct4 ChIP-qPCR plotted to show relative Oct4 
occupancy in the regulatory regions of ES cell-specific genes upon OE of CAG factors. Error bars 
depict standard deviations of biological triplicates.  
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signatures were modulated by CAG factors. As shown in Figure 4.12B, upon induction 
and removal of dox, we observed modest changes in H3K27ac marks within ES cell-
specific enhancers. In contrast, induction of Arid3a significantly increased the levels of 
H3K27ac at the enhancers of TS cell-specific genes. Finally, upon removal of dox, levels 
of H3K27ac decreased, indicating Arid3a-dependent regulation of H3K27ac on TS cell-
specific genes.  
Next, we previously determined that Arid3a interacts with Hdac1. Since HDACs are 
responsible for deacetylation of H3K27ac (Urvalek and Gudas, 2014), we performed 
Hdac1 ChIP in these Arid3a OE cells shown in Figure 4.12A, followed by qPCR to 
monitor the enrichment of Hdac1 at regulatory regions of ES cell-specific as well as at 
TS cell-specific genes in these cells. We observed strong enrichment of Hdac1 at the 
Figure 4.12. OE of Arid3a in ES cells initiates ES to TS-like cell reprogramming through changes in 
histone signatures on the enhancers. (A) Cell morphologies of ES cells and Arid3a-inducible ES cells 
upon either treatment with doxycycline (dox) for 4 days or following withdrawal of dox. (B,C) 
H3K27ac (B) and Hdac1 (C) ChIP-qPCR showing relative levels of H3K27ac in the regulatory regions 
of ES cell-specific genes (red) and TS cell-specific genes (green).  
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enhancers of ES cell-specific genes but no enrichment of Hdac1 at the regulatory 
elements of TS cell-specific genes in early stage of the reprogramming (Figure 4.12C). 
Conversely, the shutdown of Arid3a induction by dox withdrawal reduced enrichment of 
Hdac1 at ES cell-specific enhancers (Figure 4.12C). Together, our results provide 
evidence that OE of Arid3a in ES cells initiates ES to TS-like cell reprogramming 
through changes in histone signatures on the enhancers. 
4.4 DISCUSSION 
Reprogramming is lineage-specific, TF-mediated conversion of one cell type to another. 
Yet the underlying mechanism by which TFs initiate and complete the reprogramming 
process has remained elusive. We show here that ectopic expression of CAG factors in 
ES cells promotes dynamic changes in global gene expression as well as within the 
chromatin landscape during the early stages of reprogramming to TS-like cells. Previous 
studies proposed the concept of pioneer factors, which initially bind preferentially to 
heterochromatin of cell-type-specific genes and further remodel this “closed” chromatin 
structure into an accessible, “open” version. CAG factors occupy closed chromatin within 
ES cells to activate silenced genes essential for TS cell identity, suggesting that they 
partially have pioneer factor-like activity. However, surprisingly, CAG factors also 
repress ES cell-specific genes. Upon OE, they prefer to bind within open rather than 
closed chromatin of ES cells to repress genes essential for maintenance of pluripotency. 
Consistent with many TFs, CAG factors bind to distal regulatory elements (i.e., 
enhancers) and modulate epigenetic features such as histone modifications to shift the 
entire transcriptional program to that of the target cell type.  
Consistent with previously identified pioneer factors which bind to DNA via 
recognition of specific sequence motifs, our analyses revealed that the binding sites of 
CAG factors within closed chromatin contain degenerate, “partial” versions of their 
canonical motifs. Conversely, their binding sites within open chromatin lack canonical 
CAG motifs, suggesting that CAC factors may require interactions with other factors to 
facilitate their recruitment to these non-consensus open target sites. Crucial to this 
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argument is our observation that CAG factor binding appears to convert open regions of 
chromatin within ES cells to heterochromatin within TS-like cells. This leads to 
repression of ES cell-specific genes as well as accessibility of closed regions of 
chromatin corresponding to genes involved in TE development. Our integrative analysis 
of CAG factor occupancy, gene expression, and chromatin accessibility at different 
stages of early reprogramming revealed a timely and ordered binding strategy, followed 
by alterations within chromatin landscapes as well as dramatic changes in global gene 
expression.  
These observations led us to a step-wise model in which, initially, CAG factors 
predominantly occupy open chromatin of ES cell-specific genes to deactivate them. 
Then, they switch their binding site preference onto the regulatory elements of TS cell-
specific genes for activation. Both deactivation and activation appear to be associated, if 
not mediated, by histone modifications, as levels of H3K27ac within enhancers change 
significantly over the course of reprogramming. This mechanism requires dynamic and 
sequential occupancy changes within the binding of CAG factors, as they must adjust 
their specificity from ES cell-specific to TS cell-specific in a timely, ordered manner. To 
our knowledge, this is the first example of a step-wise mechanism of TF-mediated 
reprogramming elucidated at both transcriptional and epigenetic levels. These events, 
which underlie the reprogramming of ES cells to TS-like cells, uniquely expand the 
established mechanisms of pioneer factor-mediated transactivation. However, this is yet 
limited to reprogramming from ES cells to TS-like cells. 
Recent studies have employed mouse embryonic fibroblasts (MEFs) to establish so-
called “induced” trophoblast stem cells (iTS) cells (Benchetrit et al., 2015; Kubaczka et 
al., 2015). However, there are unique advantages in employing ES cells to generate 
functional TS-like cells. Compared to MEFs, mouse ES cells contain far more open 
chromatin structure (Mikkelsen et al., 2007). Indeed, both ES cell-specific genes as well 
as some TS cell-specific genes are accessible in ES cells. Such configuration might 
facilitate not only the binding of CAG factors, but the time required for reprogramming. 
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For example, generation of iTS cells from MEFs usually takes ~3 weeks, whereas 
reprogramming of ES to TS-like cells takes less than one week to initiate changes in 
transcriptional programs and to generate functional TS-like cells ex vivo (Rhee et al., 
2014). In addition, this sequential step-wise mechanism may be due to the fact that closed 
chromatin - the status of repressed TS cell-specific genes in MEFs - delays 
reprogramming.  
Taken together, our systematic approach of analyzing CAG occupancy, 
transcriptomic and epigenetic changes during reprogramming of ES to TS-like cells 
broadens our understanding of the mechanism underlying TF-mediated reprogramming. 
Our stepwise and integrative dissection of the initial steps of reprogramming may help 
improve both the efficiency of the reprogramming process as well as facilitate stem cell 
therapies in patients whom rely on changing the fate of their own cells for treatment.   
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CHAPTER 5: SUMMARY AND FUTURE DIRECTIONS 
SUMMARY 
During my doctoral studies, I have investigated transcriptional and epigenetic 
regulation of the first cell fate decision during early embryonic development and ES to 
TS-like cell reprogramming. I have employed a broad panel of molecular biological 
approaches, along with high-throughput genomics and computational analyses. Together, 
I have attempted to present a holistic picture by addressing mechanisms of development 
and reprogramming and their validation in vivo and ex vivo. 
First, I observed that Arid3a, a previously characterized transcriptional activator of B-
cell development, is a critical regulator for controlling the first cell fate decision and 
placental development. I demonstrated that ectopically expressed Arid3a drives induction 
of TE-like transcriptional programs in ES cells. Arid3a is not only required for the 
maintenance of self-renewal of TS cells, but also promotes further trophoblastic lineage 
differentiation. I determined that, consistent with the in vitro results, Arid3a
–/–
 mice suffer 
severely impaired post-implantation development, which results in early embryonic 
lethality. Mechanisms underlying this essential Arid3a function include regulated nuclear 
entry-export, HDAC-mediated deacetylation of target genes, and regulation of embryonic 
hematopoiesis. Collectively, my studies revealed that Arid3a functions as a pivotal 
regulator of TE and placental development by regulating commitment to the first cell fate 
as well as by the execution of TE lineage differentiation. 
Second, I studied the mechanisms underlying transcription factor (TF)-mediated 
trans-differentiation/direct reprogramming of mouse ES to TS-like cells. I addressed this 
mechanism specifically via the TS cell-specific TFs Cdx2, Arid3a, and Gata3 (CAG 
factors). I carried out time–course profiling of chromatin accessibility, transcriptomes, 
and occupancy of reprogramming factors during direct ES to TS-like cell conversion. I 
discovered that CAG factors orchestrate conversion via a two-step mechanism: 1) initial 
repression of ES cell-specific genes by decommissioning of active enhancers and 2) 
direct activation of TS cell-specific genes via accession of closed chromatin by 
 108 
employing different DNA binding motifs during reprogramming. My data support a 
sequential gene regulation mechanism in which the exit of ES cells from pluripotency 
states is followed by the activation of TS cell-specific genes, leading to the conversion of 
ES cells to multipotent TS-like cells. 
UNDERSTANDING EPIGENETIC MARKS AND SIGNALING PATHWAYS OF THE ES TO TS-
LIKE CELL REPROGRAMMING 
Although it has been established that several TFs (~9 TFs) play critical roles in the 
first cell fate decision, it is unknown when and how epigenetic marks arise and fade away 
during this crucial point in development. It is also unknown what role such marks play 
during ES to TS-like cell reprogramming. This is vital to consider, as histone 
modifications have vast implications for gene expression by promoter silencing, RNA 
polymerase recruitment, and other mechanisms. This question can be addressed by 
identifying essential epigenetic modifiers during the ES to TS-like cell transition, 
including their target sites within the genome and determination of the mechanism(s) by 
which they are recruited or suppressed by cell type-specific TFs. Understanding such 
developmentally regulated epigenetic signatures will be crucial in unraveling key features 
of the previously observed epigenetic plasticity during this transition. Progress in this 
area is essential for the ultimate goal of developing safe cell therapies and regenerative 
medicines. 
In addition to discerning ES to TS-like cell reprogramming of transcriptional and 
epigenetic regulation, understanding the signaling pathways governing self-renewal and 
multipotency in mouse TS cells is crucial. Although the Ras/Mapk and Nodal signaling 
pathways are strongly implicated, each signaling pathway participates in crosstalk with 
other pathways; thus, it is vital to establish a signaling network to better understand how 
distinct trophoblast lineages are specified—e.g., what TFs regulate differentiation to giant 
cells vs. labyrinthine cells. The benefits of constructing such a network are numerous. 
After all, the use of chemical inhibitors that target specific signaling pathways has 
allowed the derivation of pluripotent ES cells across species and facilitated creative 
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approaches to cell reprogramming. Additionally, understanding signaling in the ES to 
TS-like cell reprogramming context may enable development of a chemically defined 
media to culture and maintain TS cells. This would eliminate the variability and ethical 
issues inherent in serum use, as well as link individual signaling components to vital 
transcriptional targets. 
GENERATION OF HUMAN TS CELLS 
Although derivation of human TS cells has failed to date, human TS cells can provide 
a highly valuable tool to study genetic and epigenetic control mechanisms of trophoblast 
proliferation, differentiation, and function in normal and pathological placentation during 
human embryogenesis. Human TS cells may also provide a huge benefit for human 
health. The failure of viable derivation of human TS cells highlights the critical need for 
understanding embryonic development on a molecular level. Nevertheless, and similar to 
what we observed in mouse ES cells, transient induction of ARID3A can up-regulate TE-
associated factors such as GATA3 and TFAP2C while down-regulating levels of OCT4 
and NANOG. Thus, the regulatory function of mouse Arid3a during placental 
development may be conserved between mouse and human. This means that our 
discoveries regarding the function of Arid3a in mouse reprogramming and hematopoiesis 
would provide helpful starting points for examining their role in humans. In addition, in 
the future, these studies might be lead to isolation and culturing of human TS cells. 
Unfortunately, the human implantation process is still poorly understood. The loss of 
potential embryos occurs relatively frequently due to the loss of blastocysts before or 
around implantation. Thus, it will be essential to decipher how TS cell-specific TFs are 
conserved in the human placentation process and to examine how their deregulation 
affects serious pregnancy diseases, such as pre-eclampsia. Once viable human TS cells 
are generated, they may be used in the future to treat the many pregnancy-related 
disorders that appear to involve dysregulated trophoblast differentiation. 
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TS CELL TRANSCRIPTIONAL NETWORK 
Proper trophoblast differentiation is essential for placental development and 
successful mammalian reproduction. Paradoxically, despite its fundamental importance, 
the placenta remains one of the least understood organs in mammals. There are only a 
few TFs identified to date that are implicated in trophoblast lineage specification. This 
short list includes ARID3A. Although the ES cell pluripotency network is well-
characterized, TS cell regulatory networks remain insufficiently understood. Also, it is 
unknown how TS cell-specific TFs regulate one another to maintain self-renewal and 
multipotency. We hypothesize that, analogous to ES cells, TS cells are maintained via 
positively regulated feedback loops governed by multiple TS cell-specific master TFs. 
Perturbations in this network then cause an exit from multipotency and result in terminal 
differentiation into specialized placental cells. This is crucial to consider, as improper or 
unbalanced differentiation of placental lineages is a hallmark in placental disorders. 
Indeed, such differentiation defects also pose risks for congenital malformations, pre-
eclampsia, and miscarriage. 
In the age of genome sequencing and massive biological data sets, systems-level 
approaches have become increasingly critical for understanding biological processes. 
Construction of a TS cell-specific regulatory network would be a great asset to the fields 
of development, differentiation, and medicine. It is our great hope that the present studies 
delineated in this dissertation may catalyze further advances in placental biology and 
trophoblast development. 
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APPENDIX 
APPENDIX A. RT-QPCR PRIMERS 
 Forward Reverse 
Arid3a AGGTTATCAACAAGAAACTGTGGAG TACTTCATGTACTGTGTCCGAAGTG 
Bmp2 CGCTTCTTCTTCAATTTAAGTTCTG AACTACTGTTTCCCAAAGCTTCCT 
Bmp5 AGCCTACATGATACCAACTTTCTGA GATCAAACCGAAACTCTTTGTAATG 
Cdx2 GCGAAACCTGTGCGAGTGGATG CGGTATTTGTCTTTTGTCCTGGTTTTCA 
Cxcr4 ATGGAACCGATCAGTGTGAGTAT AAGATCCTATTGAAATGGACGTTTT 
Dlx3 CTCACACAAACACAGGTGAAAATCT ATGGAGTCACTGTTGTTGGGG 
Fgf5 GGATTGTAGGAATACGAGGAGTTTT AACTTACAGTCATCCGTAAATTTGG 
Gapdh AAATTCAACGGCACAGTCAAG CACCCCATTTGATGTTAGTGG 
Gata2 GCCTCTACCACAAGATGAATGG GTCTGACAATTTGCACAACAGG 
Gata3 TGGGCTGTACTACAAGCTTCATAA CTTTTTCGATTTGCTAGACATCTTC 
Gata4 TTCTCAGAAGGCAGAGAGTGTGT ATGCCGTTCATCTTGTGATAGAG 
Gata6 GACGGCACCGGTCATTACC ACAGTTGGCACAGGACAGTCC 
Gcm1 TGTTGAGCAGACCTTATCATGGAA GTCAGTCGTTTTCACGTTCTGAG 
Gsc AGAAGGTGGAGGTCTGGTTTAAG GAGGACGTCTTGTTCCACTTCT 
Hand1 CCTTCAAGGCTGAACTCAAAAA GCGCCCTTTAATCCTCTTCT 
Hoxb1 AGGTCAAGAGAAACCCACCTAA AAATGAAATTCCTTCTCCAGCTC 
Id2 ATCACCAGAGACCTGGACAGAAC GCTATCATTCGACATAAGCTCAGA 
Isl1 GGGATGGGAAAACCTACTGTAAAAGAGA GTCGTTCTTGCTGAAGCCTATGCTG 
Klf4 CTGCAGCTTGCAGCAGTAAC AGCGAGTTGGAAAGGATAAAGTC 
Krt8 AGAACATGAGCATTCATACGAAGA GAGCTCATTCCGTAGCTGAAG 
Nanog AGGGTCTGCTACTGAGATGCTCTG CAACCACTGGTTTTTCTGCCACCG 
Nes AGGACCAGGTGCTTGAGAGA TTCGAGAGATTCGAGGGAGA 
Oct4 CTGAGGGCCAGGCAGGAGCACGAG CTGTAGGGAGGGCTTCGGGCACTT 
Otx2 AAGTGAGTTCAGAGAGTGGAACAAG CTCCAGATAGACACTGGAGCACT 
Sox17 CTAAGCAAGATGCTAGGCAAGTCT GTACTTGTAGTTGGGGTGGTCCT 
Sox2 GCGGAGTGGAAACTTTTGTC TATTTATAATCCGGGTGCTCCT 
T CTTCAAGGAGCTAACTAACGAGATG GTCCAGCAAGAAAGAGTACATGG 
Tcfap2c CCACGTCGAAGTACAAAGTAACTG TTTTTGGACTTTGCTCTTCTGAG 
Tpbpa GCAAGAGCAGAAGGATAAAGAAGTT CACTCATTTCTATGTTGGAGCCTTC 
Wnt2 TTAATATGAACGTCCCTCTCGGTG GTAGCTCTCATGTACCACCATGAA 
ARID3A GGACTCTGCTGTGAACCTGAC GGCTGAGCAAACAGAACTCCT 
CDX2 CTGGAGAAGGAGTTTCACTACAGTC AACCAGATTTTAACCTGCCTCTC 
GATA3 GGGCTCTACTACAAGCTTCACAATA CACTTTTTGGATTTGCTAGACATTT 
GCM1 GACGCTTTATATTTTTCCAGTCAAA AAGGTGCTGTGTTCACTTTCTTC 
OCT4 AAGGAGAAGCTGGAGCAAAAC GTATATCCCAGGGTGATCCTCTT 
NANOG CCAGAACCAGAGAATGAAATCTAAG AAGAGTAAAGGCTGGGGTAGGTAG 
GAPDH TTGGAACATGTAAACCATGTAGTTG AGTCAACGGATTTGGTCGTATT 
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APPENDIX B. CHIP-QPCR PRIMERS 
 
  Forward Reverse 
Arid3a_3.8K_Down ACTCTCATTCAGAGGCAGCAG CCTGTCCTCATCTGTCATGGT 
Arid3a_Proximal CAAGATCCCCACAACAGTCTAAC AAGTTGAGACGATTCTAGTGGGTAA 
Cdh3_0.5K_Down AAACTTAAAAGTGGAGGGTCATTTC AAAATCCCACTGTCCTCTGTAGTC 
Cdh3_3K_Up GAAGAGCTGAGTATCGTTTTCTCC CTAATTAAGTAAACACTCGGCTGGA 
Cdx2_0.5K_Down CCTCCTTGCCAGTAAGCTGTAG GTCTTGTAAACACTCGTTAATCACGTA 
Cdx2_2.2K_Down TGATGTTAATGTAGGGAAGCTGTG GGGCTGAAAGGTGTACATCAA 
Cdx2_Proximal GTCTTGTAAACACTCGTTAATCACGTA CCTCCTTGCCAGTAAGCTGTAG 
Fgf4_10K_Up TCTCTTCCCAGAGGTGAAGGT CAGGGTATATCTCTGTTCAGTCTCC 
Gata3_4.5K_Up GAGATGCGTTTAATTCGATTCC TTCTTTTACAACTTCCATGCCTAAG 
Gfi1b_Proximal CGCCAGATTTTGACACAAATAA CTGCACAGACAGACACTTCTCC 
Id2_0.7K_Up CTCAGTGACACGAATTGTAGGAAC GAGTCATTATAGTAACCCTGCCTCA 
Id2_Proximal GCATTTACCAAACCAAACATTTAAC AGCTTATGTCGAATGATAGCAAAGT 
Klf4_1.9K_Down GAGAATCTGCGCCACCTC CGGAATGTATACTGGGTCCAAC 
Klf4_1K_Down CCTAATATTGACTTGTTGGGTGAAG TCTTACCTTGGTGTTAGCTGAGATT 
Nanog_0.2K_Up GATGAATAAAGTGAAATGAGGTAAAGC GTAATGCAAAAGAAGCTGTAAGGTG 
Nanog_4.7K_Up AAAGACACTAAAGAGGCAGGACAG GTTTACCCCAAGTTCTACAAAGGTT 
Nanog_4K_up CATTTCTTTCCTTAGTGAGATTGGA ATATTGAAGGACAATAGGCATTCTG 
Oct4_2K_Up CATAACAAAGGTGCATGATAGCTC ACAAAGCTTCCTCAATAGCAGATTA 
Oct4_Proximal GTCTGGAAGACACAGGCAGATAG ACCCTCTAGCCTTGACCTCTG 
Pecam1_9K_Up GCTGCAATCAATTTTATTTAACCAG TAATGCTAAATTCTGTACCCAGAGG 
Rest_1K_Down TTTATTCTTTGCATATCTTGCCTTT TGAGTTTCTAAATGGTCTCAACCTC 
Rest_3.4K_Up TGATTTTCTCCTGGTTAAGAGTTTG AACAAAATCTAAGTGCCTGCCTAC 
Sall4_2.3K_Up CTGCTCAAGGCATTGTAAGCTAT AGACAGAAGTGGAAGAAGCCTTT 
Tbx3_0.4K_Up GCAGGAGCTAGAGGATCTGACT GCCAATAAGCCTTAACAAAAGC 
Tbx3_0.5K_Down CATGAGACTATGCACCTTGTATTTG GGTGGTTTTAAACACTAGTCATTGG 
Tcfap2c_4.7K_Up GTCATAAAATCTCTTTGTGCCCTTA GTATAAAAGGAAACACAGACAAAGAGG 
Zfp42_Proximal GCATCCTCTGCTTGTGTAAATTC CTCAGTTATGCAAATGCCTCTTC 
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APPENDIX C. CLONING PRIMERS 
 
  Forward Reverse 
FB_Arid3a CGCGGATCCTCAAGCTGCAGGCT
GTGATGGAG 
CGCGGATCCTTAAGGCAAGGAGT
TGTTTG 
FB_Cdx2 CGCGGATCCTCTACGTGAGCTAC
CTTCTGG 
CGCGGATCCTCACTGGGTGACAG
TGGAGTTTAAAAC 
FB_Gata3 CCGAGCTCGAGGATCCTCATGGA
GGTGACTGCGGACCA 
TAGAACTAGTGGATCCCTAACCC
ATGGCGGTGACCA 
pEF1alpha_IRES_Zs
Green_Arid3a 
CGCTGCTAGCATGAAGCTGCAGG
CTGTGATGG 
CGCTGAATTCTTAAGGCAAGGAG
TTGTTTGAG 
pEF1alpha_IRES_Zs
Green_Cdx2 
CGCTGCTAGCATGTACGTGAGCT
ACCTTCTGG 
CGCTGAATTCTCACTGGGTGACAG
TGGAG 
pMSCV_Arid3a CTCTCTCGAGGCGATGAAGCTGC
AGGCTGTGATGGAG 
CTCTGAATTCGCGTTAAGGCAAG
GAGTTGTTTGAGGTAG 
pGEM-in situ-
Arid3a 
GCGGACCCCAAGAGGAAAGAGTT CTGGGTGAGTAGGCA 
AAGAGTGAGC 
Inducible_Arid3a GCCCCCGGGACGCGTATGAAGCT
GCAGGCTGTGATGGAG 
CTACCCGGTAGAATTCTTAAGGCA
AGGAGTTGTTTGAGGT 
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